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Abstract 
 
Title: The use of gastroscopy in the evaluation of treatment response of Equine Gastric Ulcer 
Syndrome (EGUS) 
Despite the existence of effective treatment (Omeprazole) for EGUS, given the high cost and 
recurrence rate, it is essential to take preventive management and dietetic measures.  
The purpose of this retrospective study was to evaluate the treatment response with omeprazole 
using gastroscopy, identify risk factors associated with the appearance of gastric lesions and 
evaluate the effect of management changes in the prevention of recurrence, between the years 
of 2010 and 2015.  
69 horses with suspected EGUS were evaluated by physical examination, gastroscopic 
examination and measurement of gastric fluid pH values. The final sample group were the 22 
horses with confirmed lesion grade≥1 in the first gastroscopy, then treated with omeprazole 
4mg/kg bwt, PO, SID, for 28 days, followed by 2mg/kg bwt, SID, PO, for another 28 days, and 
recommended management and nutritional measures. After this period, all horses were re-
evaluated. Information was gathered from the horse’s owners using two questionnaires 
regarding clinical complaints at both examinations and regarding treatment follow-up.  
The occurrence of EGUS was confirmed in 100% (n=69). Clinically relevant symptomatology 
was identified, were signs of colic in the last year was the most frequent clinical complaint 
(59,10%) and was significantly associated with higher numeric scores (p=0,029) whereas the 
coat condition was significantly associated with severity score (p=0,038). After treatment, there 
was a general improvement of the lesions and clinical signs, with total remission of the lesions in 
4,5% (n=2/22). Owner’s responses on signs of colic (p=0,031) and body weight (p=0,008) and 
body weight registered at physical examination (p=0,011) were statistically different, along with 
an increase in mean pH values show evidence of a certain level of efficacy of treatment with 
omeprazole. None of the presumable risk factors were found significantly associated with the 
presence or degree of gastric ulceration (p>0,05). Still, exercise and administration of NSAIDs 
may have determined a lower treatment response. No significant changes in ulcer scores were 
identified for any levels of implementation of management measures. Nevertheless, decreased 
ulcer scores were identified in 45,5% (n=10/22) in those who implemented the management 
changes in some way.  
 
Keywords: Equine Gastric Ulcer Syndrome, gastroscopy, omeprazole, management, treatment. 
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Resumo 
 
Título: Utilização de gastroscopia na avaliação da evolução do tratamento de Síndrome de 
Úlcera Gástrica Equina (SUGE) 
Apesar da existência de tratamento eficaz (Omeprazol) para SUGE, dado o elevado custo e 
taxa de recorrência, é essencial tomar medidas preventivas de maneio ambiental e dietética.  
O objetivo deste estudo retrospectivo foi avaliar a resposta ao tratamento com Omeprazol 
utilizando gastroscopia, identificar fatores de risco associados ao aparecimento de lesões 
gástricas e avaliar o efeito das alterações de maneio na prevenção de recorrência, entre os 
anos de 2010 e 2015.  
Foram avaliados 69 equinos com suspeita de SUGE por exame físico, exame gastroscópico e 
medição dos valores de pH gástrico. A amostra final foi de 22 equinos com lesões grau≥1 
confirmados na primeira gastroscopia, tratados com Omeprazol 4 mg/kg PV, PO, SID, por 28 
dias, seguido de 2mg/kg BWT, SID, PO, por mais 28 dias, e recomendado alterações de 
maneio ambiental e dietético. Após esse período, todos os equinos foram reavaliados. 
Informação a respeito das queixas clínicas em ambos os exames e do seguimento do 
tratamento foi recolhida dos proprietários dos cavalos usando dois questionários.  
A ocorrência de EGUS foi confirmada em 100% (n=69). Foi identificado sintomatologia 
clinicamente relevante, tendo sido a queixa clínica mais frequente sinais de cólica no último ano 
(59,10%, n=13/22) estando associada significativamente com o grau numérico (p=0029), 
enquanto a condição de pelagem foi significativamente associada ao grau de gravidade 
(p=0038). Após o tratamento, verificou-se uma melhoria geral das lesões e dos sinais clínicos, 
com remissão total das lesões em 4,5% (n=2/22). As respostas dos proprietários sobre sinais 
de cólica (p=0,031) e peso corporal (p=0,008) e peso corporal registados no exame físico 
(p=0,011) foram estatisticamente diferentes, juntamente com um aumento nos valores médios 
de pH mostram evidências de um certo nível de eficácia do tratamento com Omeprazol. 
Nenhum dos fatores de risco foram encontrados significativamente associados à presença ou 
grau de ulceração gástrica (p > 0,05). No entanto, o exercício e a administração de AINEs 
podem ter determinado uma resposta de tratamento mais baixa. Não foram identificadas 
alterações significativas nos graus de úlcera tendo em conta níveis de implementação das 
medidas de maneio diferentes. No entanto, foi identificada a diminuição do grau de ulceração 
em 45,5% (n=10/22) naqueles que implementaram as mudanças de maneio de alguma forma.  
 
Palavras-chave: Síndrome de Úlcera Gástrica Equina, gastroscopia, omeprazol, maneio, 
tratamento. 
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I. Report on the activities developed during the curricular internship 
This report concerns the curricular internship from the integrated master’s degree in veterinary 
medicine. The internship took place at the Equine Unit of the Teaching Hospital, Faculdade de 
Medicina Veterinária, Universidade de Lisboa (FMV-ULisboa).  
In the last two years of her integrated Masters, the author took an on and off training period 
starting in September 2013, while finishing her studies, working under the guidance of Professor 
Paula Tilley, and under the supervision of Dr Joana Simões, Professor Rita Garcia da Fonseca, 
and Professor Luis Lamas. Following this period, she started the curricular internship per se in 
2016 for seven months, between March and September. Overall, the author summed a total of 
1500 hours of training.  
During this time, she collaborated in several services of the hospital, such as internal medicine, 
imaging services, surgical services and postoperative care, as well as accompanying Professor 
Tilley on house calls.  
The Equine Unit of the FMV-ULisboa is considered a referral hospital, but also provides primary 
and preventive health care programs, as well as a wide range of medical, surgical and dental 
services, as well as an emergency service 24hours a day, 365 days a year. 
In the internal medicine service, she observed several cases of prophylactic care, namely 
vaccination and wellness care, preventive dental care, equine identification, blood sampling for 
identification purposes, microchipping, deworming, and prepurchase examination. Besides 
prophylactic care, there were other consultations with appointments of different departments 
such as dermatology, gastroenterology, odontology, orthopaedics, trauma, neurology, 
ophthalmology, oncology, cardiology, pneumology, andrology, gynaecology and obstetrics, 
neonatology, intensive care and parasitology.  
While in the internal medicine service, a variety of cases were observed, from physical 
examinations of patients to assisting the responsible physician with any medical acts and 
diagnostic techniques. These included a wide range of minimally-invasive procedures, in 
particular, digital radiology, ultrasound (musculoskeletal, cardiac, pulmonary, abdominal and 
obstetric) and endoscopy (gastroscopy, vaginoscopy, rectoscopy, static and dynamic upper and 
lower respiratory endoscopy).   The author assisted the physician in charge by preparing the 
patient for the exam, preparing and placing of the necessary equipment, as well as the cleaning 
and disinfection of the equipment (ultrasound probe and endoscope). 
While in the surgery service she was involved in several procedures, starting with the 
preparation of the operating room, next in the preoperative care of the surgical patient, 
performing a physical examination of the surgical patient, administering the proper medication 
prescribed by the surgeon, as well as the anaesthesiologist, and postoperative care. 
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The author had the opportunity to assist in small procedures such as skin suturing, drainage and 
removal of abcesses, as well as large procedures such as castration, tenotomy, exerisis of 
tumours, rectum and perineum reconstruction. 
The surgeries that were observed took place in the operating room of the hospital or in the field.   
During postoperative care, the author was responsible for monitoring vital signs of recovering 
patients and administering the medication prescribed by the supervising physicians. 
During this period the author also collaborated in a few courses that took place at the teaching 
hospital of FMV-ULisboa, such as the XXXIX Jornadas Médico-Veterinárias (Dynamic 
Endoscopy Workshop) which took place in October of 2015, and the “Avaliação cardio-
respiratória, endoscopia no cavalo e ecografia do aparelho musculo-esquelético” in November 
of 2015. 
The necessary information was gathered for this study during this time frame, namely the chart 
information of suspected patients of Equine Gastric Ulcer Syndrome (EGUS), such as their 
physical examination, weight, gastroscopy examination, gastric pH level, and epidemiological 
questionnaire.  The development of this work was accepted to be presented as a poster at the IV 
Jornadas do Grupo de Trabalho de Investigação em Equídeos, Golegã (November 2015) 
(available in Annexe 1). 
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II. Literature review  
1. Introduction 
Equine gastric ulcer syndrome (EGUS) is a wide-reaching and common disorder in the horse 
regardless of age, gender, or breed. It has been considered a conundrum for several decades 
by practitioners, horse owners, riders and trainers for its economic impact and clinical 
importance, due to its high prevalence, unspecific clinical signs and negative impact on 
performance (Nadeau & Andrews, 2009).  
Many risk factors have been implicated in the aetiology of this syndrome, such as stress, diet 
and feeding routine, type and intensity of exercise, stall-confinement and the administration of 
non-steroidal anti-inflammatory drugs (NSAIDs) (Sykes & Jokisalo, 2015). Despite many efforts, 
due to the nonspecific nature of the symptomology and the absence of specific biochemical and 
haematological parameters, endoscopic examination remains the only reliable method to 
determine a definite diagnosis (Sykes, Hewetsen, Hepburn, Luthersson & Tamzali, 2015).  
 
2. Terminology 
The term EGUS was first recognised in a consensus compiled by the Council in 1999 to 
describe gastric ulceration in the horse (Andrews, Bernard,et al., 1999). However, since then, 
the term has been misused, and therefore, an effort has been made to define and elucidate the 
terminology appropriately (Merritt, 2009). Similarly, in Human Medicine, the term peptic ulcer 
disease (PUD) is considered a hypernym to define ulcerative lesions in the oesophagus, 
stomach and duodenal mucosa (Malfertheiner, Chan, & McColl, 2009).  
Recently the terminology has been polished, recognising EGUS as the blanket term to describe 
gastric ulceration, while distinguishing Equine Squamous Gastric Disease (ESGD) and Equine 
Gastric Disease (EGGD) separately according to the affected anatomic region (Sykes, 
Hewetson, et al., 2015). Therefore, it is unfitting to extrapolate the knowledge of one syndrome 
to the other. Furthermore, collection of information is required for each condition due to the 
stated differences between the squamous and glandular mucosae, which include differences in 
prevalence within a population (Begg & O’sullivan, 2003; Habershon-Butcher, Hallowell, Bowen 
& Sykes, 2012; Luthersson, Hou Nielsen, Harris & Parkin, 2009b; Murray Nout & Ward, 2001b; 
Tamzali, Marguet, Priymenko & Lyazrhi, 2011), risk factors (Habershon-Butcher et al., 2012), 
response to treatment with omeprazole and prevention (Sykes, Sykes, & Hallowell, 2014d, 
2014a, 2015). However, the presence of squamous and glandular ulceration within an individual 
was found unrelated (Begg & O’sullivan, 2003; Luthersson et al., 2009b; Murray, Nout, et al., 
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2001b). A synopsis of the reinforced and recommended terminology of EGUS is displayed in 
Figure 1.   
 
Figure 1 – An overview of the recommended terminology for describing equine gastric erosive 
and ulcerative diseases (Adapted from Sykes et al., 2015). 
 
 
3. Anatomy of the equine stomach and gastric acid secretion 
The horse’s stomach consists of a single composite large chamber interposed between the 
oesophagus and small intestine (König & Liebich, 2004). The oesophagus joins the stomach 
through the cardia in the right median plane of the abdomen, while the pylorus continues into the 
duodenum more to the left, both of which are controlled by sphincters (König & Liebich, 2004). 
The cardiac sphincter in the horse is very well developed, and this, together with the oblique 
entrance of the oesophagus is believed to be responsible for the presumed inability of the horse 
to vomit. Although vomiting and regurgitation are considered rare, it may occur (König & Liebich, 
2004).  
It possesses visceral and parietal surfaces and greater and lesser curvatures (König & Liebich, 
2004). The lesser curvature is very short, compared to the greater curvature, causing the cardia 
and pylorus to have a nearby location (Sisson, 1986). 
The stomach’s position is closely related to the development of the greater omentum and the 
lesser omentum (König & Liebich, 2004).  Also, the exact shape and position depend on the 
degree of filling (König & Liebich, 2004). Still, the physiological capacity varies between 5 and 15 
litres, which is smaller compared to the size of the animal and the volume of forage it consumes 
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(Dyce, Sack & Wensing, 2004). This fact should be considered when administering fluids via a 
nasogastric tube to avoid overdistension (König & Liebich, 2004). 
The structure of the gastric wall is the same as that of the oesophagus and consists of the 
following layers, inward to outward: mucosa, submucosa, muscular layer and serosa (König & 
Liebich, 2004).  
The mucosa can be divided into two core regions: the non-glandular region and the glandular 
region (Figure 2). The squamous non-glandular region includes the dorsal third of the stomach 
(orad), which is covered with stratified squamous epithelium, identical to the one found lining the 
oesophagus, as well as the entrance to the stomach via the cardia (Hepburn, 2011). 
Histologically, no glandular structures of any kind are found within it that could establish 
assumed digestive or mucosal protective mechanisms. Further, it was found that in an Ussing 
chamber it maintains no short circuit current, demonstrating the absence of active transport 
processes (Merritt, 1999). The functional role of this region is yet to be determined (Hepburn, 
2011). However, it is believed that since it is not generally exposed to acid, it allows fermentative 
digestion processes to occur (Klein, 2013).  
 
Figure 2 - A post mortem specimen of the equine stomach illustrating the anatomical regions of 
the stomach (Addapted from Hepburn (2011)). 
 
 
 
Legend: A–Equine gastric mucosal anatomy; B–Illustration of gastric pH and content stratification.  
a-Oesophagus; b-Squamous fundus; c-Greater curvature; d-Lesser curvature; e-Cardia; f-Margo plicatus; 
g-Glandular fundus; h-Pylorus region; i-Pylorus; j-Duodenum; k-Low density matter (pH 5-7); l-Medium 
density matter (pH 4-5); m-High density matter (pH 1-2). 
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The margo plicatus is the delineation region between the squamous and glandular regions of the 
stomach that lines the distal half of the equine stomach (Hepburn, 2011). Some authors have 
considered the margo plicatus as part of the non-glandular mucosa, while others found that, due 
to its distinct and complex capillary network and susceptibility to ischemic lesions, it should be 
seen as an independent region in the transition between the two mucous membranes (Staszyk, 
Jackowiak, Godynicki, & Gasse, 2001).  
The distal two-thirds of the stomach is covered with glandular mucosa, which can then be 
divided into three regions: glandular fundus (body), pyloric antrum and cardiac glandular region. 
The glandular fundus (body) occupies the mid third of the stomach, the pyloric antrum occupies 
the most distal third, and the cardiac glandular region is the narrow strip of glandular mucosa 
adjacent to the margo plicatus (Hepburn, 2011). All these areas contain similarly structured 
glands, but each has particular cell types with different functions (Klein, 2013; König & Liebich, 
2004). 
The glandular mucosa of the stomach is comprised in part of simple columnar epithelium, which 
contains gastric pits, forming the entrance into the gastric glands (König & Liebich, 2004). These 
epithelial cells, known as surface mucous cells, excrete a thick alkaline mucus that protects the 
mucosa from the highly acidic gastric fluid (Klein, 2013).  
Within the parietal region of the gastric fundus are parietal cells, zymogen (or chief) cells and 
enterochromaffin-like cells (ECL) that make up the gastric glands (Merritt, 1999).  The parietal 
cells are clustered in the neck of the gland and have the primary function of secreting 
hydrochloric acid, under the stimulation of histamine, which is produced in a paracrine 
mechanism by the ECL cells. These cells also modulate gastric mucosal blood flow via the 
action of serotonin (5-HT) (Klein, 2013). While, in the base of the gland, the chief cells secrete 
pepsinogen, the precursor to the digestive enzyme pepsin (Klein, 2013). Also, among the 
parietal cells are neck mucus cells that secrete a thin mucus, less viscous than that of the 
surface mucous cells. Besides their secretory function, they secondarily function as replacement 
epithelial cells (Klein, 2013). 
The cardiac and pylorus region resemble parietal region in structure, however, contain different 
cell types (Klein, 2013). The gastric antrum and pylorus have no parietal cells, but their ramified 
glands contain gastrin-producing G-cells (Klein, 2013). Also, a large number of somatostatin-
immunoreactive cells have been shown in this region of the equine stomach. Along with other 
functions, somatostatin has been shown to be involved in the endogenous control of gastric acid 
secretion, while sampling intragastric pH and modulating G-cell gastrin release (Merritt, 1999; 
Hepburn, 2004). These regions can be incidentally parasitised with larvae of gastrophilus 
intestinalis and may be marked by scars left after their removal (Dyce et al., 2004).  
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The cardiac mucosa, in the horse and most species, forms a narrow band around the gastric 
opening of the oesophagus, while in swine it covers a more substantial portion of the proximal 
stomach (Klein, 2013). Little is known about its function in the horse, but it is thought that the 
primary secretion is sodium bicarbonate, which may protect the adjacent oesophageal mucosa 
from the stomach’s acid secretion (Klein, 2013).  
The horse secretes gastric acid in a continuous, variable manner (Murray, 1994), and the 
median pH of the ventral stomach of 3.0 over a normal 24h period reflects this (Husted, 
Sanchez, Olsen, Baptiste, & Merritt, 2008). The acid secretion is predominantly triggered by 
paracrine, endocrine, and neural stimuli (Yao & Forte, 2003), stimulated by the gastrin, 
histamine and acetylcholine, a neurotransmitter from the Vagus nerve (Campbell-Thompson & 
Merritt, 1990).  
The hydrogen and chloride ions are secreted by different cellular mechanisms (Klein, 2013). 
However, the ability of the parietal cell to secrete acid is dependent on active transport, through 
the H+/K+ ATPase pump (Figure 3), otherwise known as proton pump enzyme, in the cell 
membrane (Yao & Forte, 2003). This acid secretion occurs against both a concentration and 
electric gradient, higher than 3 million-fold (Yao & Forte, 2003). Within the parietal cell, H+ ions 
are formed from the dissociation of water, then the hydration of CO2 leads to the formation of 
bicarbonate ion (HCO3-), a reaction catalysed by carbonic anhydrase. The bicarbonate is then 
transported out of the basolateral 
membrane in exchange for chloride (Yao & 
Forte, 2003). The discharge of bicarbonate 
into the blood leads to a small elevation of 
blood pH (alkaline tide), which serves to 
maintain intracellular pH in the parietal cell 
(Yao & Forte, 2003). Hydrogen ions are 
driven out of the cell, into the lumen, in 
exchange for potassium through the action 
of the proton pump (Forte & Zhu, 2010). 
The bicarbonate trapped in the mucous 
barrier adhering to the stomach wall forms 
a pH gradient that allows a physiological 
pH at the mucosal surface and a pH similar to that of stomach acid at the luminal surface 
(Andrews et al., 1999). 
The horse’s stomach presents a dorsoventral gradient (Figure 2B), starting with the squamous 
mucosa of the fundus (pH 5.46±1.82), followed by the squamous mucosa of the margo plicatus 
Figure 3 - Schematic illustration of the parietal 
cell transport mechanism (Adapted from 
Hepburn (2004)). 
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(pH 4.12±1.62), then the glandular mucosa of the pylorus (pH3.09±1.9), being the gastric fluid 
the most acidic (2.72±1.86) (Murray, Grodinsky, Anderson, Rague, & Schmidt, 1989).  
The gastric contents of an adult equid with a regular hay/grain diet, where the roughage is 
available on a free-choice basis, also have a similar dorsoventral layering. The roughage 
component of the diet determines this fact seeing that the dense acid liquid is trapped ventrally 
by the lower density/larger particle size components found dorsally, which is vital to normal 
gastric function (Hepburn, 2011; Merritt, 2013). Gastric emptying is continuous at a speed that 
according to the type of content, where liquid contents take only 30 minutes to reduce in half the 
volume, while solid contents take about 1·5 hours (Hepburn, 2011).   
Adult horses may secrete up to 35-40 litres of saliva per day, the majority of which is parotid in 
origin, with a pH of approximately 7.4 (Eckersall, Aitchison, & Colquhoun, 1985). Saliva 
secretion has the core function of buffering gastric pH (Bell, Mogg, & Kingston, 2007), 
consequently, feeding has the buffering effect on gastric pH through effects of increased 
production of saliva with an increase of mean intragastric pH by one to two units (Murray, Nout, 
et al., 2001a). The fasting state was shown to increase the acidity of the gastric fluid from a 
median pH of 3.1 to 1.55 (Murray, Nout, et al., 2001a). Still, evidence was found that the greater 
the dry matter content of the feed, the greater the amount of saliva secreted due in part to the 
physical composition of the meal and in part to the time needed for adequate mastication 
(Merritt, 2013).  
Hourly recordings regarding proximal gastric pH displayed a clear circadian pattern, and that the 
pH decreased during the night. This pattern was thought to be involved with the horses feeding 
behaviour during the night, associated to the fact that the horse consumes most of the daily food 
intake during the day (Husted et al., 2008). 
 
4. Gastric mucosal defence mechanisms 
The mucosal defence system is a complex and dynamic process. It is composed of numerous 
factors that permit the mucosa to remain intact despite its frequent exposure to substances with 
a wide range of temperature, pH, and osmolarity, as well as to cytotoxic substances (acids, bile 
salts, pepsin and digestive enzymes), and bacterial products capable of causing local and 
systemic inflammatory reactions (Andrews, Bernard, et al., 1999).  
The squamous nonglandular mucosa is limited in defence mechanisms, relying mainly on acid 
repulsion and intracellular buffering (Murray, 1994). Mucopolysaccharides and intercellular tight 
junctions in the superficial epithelium are the only defences against H+ entry, however minimal 
buffering capacity if still offered by the intercellular secretion of HCO3- and by intracellular 
buffers (Hepburn, 2004). The initial response of squamous tissues exposed to the acid is 
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mucosal thickening, whereas prolonged exposure to increased acidity is likely to cause 
hyperkeratosis, erosion, and ulceration (Murray, 1994).  
Gastric glandular epithelium, on the other hand, has several mechanisms to prevent injury by 
acid secretion, which include secretion of mucus, EGF, bicarbonate buffering, mucosal blood 
flow, cellular repair, and prostaglandins (Andrews, Bernard, et al., 1999).  
Of these, mucosal blood flow is considered to be the most important as it provides the mucosa 
with the oxygen and nutrients necessary to produce the mucus-bicarbonate layer and allow rapid 
turnover of epithelial cells (Wallace, 2008). It is also required for removal of VFAs produced by 
intragastric carbohydrate fermentation, and to prevent the epithelial damage to progress to 
necrosis of deeper layers of the mucosa (Wallace, 2008). 
Epidermal growth factors, which are found in salivary gland secretions, are known to promote 
mucosal protection, by inhibition of gastric acid secretion, the proliferation of gastric mucosal 
cells, and also interfere in prostaglandin synthesis process (Andrews, Bernard, et al., 1999). 
Although earlier studies regarding observation of the EGF receptor (EGFr) in gastric mucosa 
have focused on the glandular stomach of laboratory animals as an extrapolation for the human 
glandular stomach,  Jeffrey, Murray and Eichorn (2001) found significant evidence that EGFr is 
also induced in peptic-injured equine gastric squamous epithelium and its involvement in the 
healing of gastric squamous mucosal ulcers in horses. 
The mucus secreted by neck cells acts as both a protective physical barrier and lubricant against 
physical damage from ingesta, maintaining a neutral pH environment for the mucosal cells, 
besides being implicated in resisting the diffusion of protons (Andrews, Bernard, et al., 1999). 
Although the importance of the mucus layer thickness remains unknown, there is evidence that a 
change in the mucus layer may cause damage to the mucosa, and eventually ulceration 
(Wallace, 2008). In response, epithelial cells, with the help of bicarbonate secreted by the 
mucosal cells at the luminal surface, form a mucoid cap in order to maintain a high pH 
environment. The resulting inflammatory response includes an increase in mucosal blood flow, 
which helps with the mucoid cap and facilitates leukocyte recruitment and plasma exudation. If 
this response is weakened, then mucosal repair is slowed or halted, resulting in gastritis or 
ulceration (Wallace, 2008). 
The prostaglandins (PGE1 and PGE2) promote numerous protective functions within the gastric 
mucosa (Murray, 2010). These substances promote gastric mucosal blood flow, maintain 
intercellular tight junctions, stimulate bicarbonate and mucus secretion leading to suppression of 
HCl secretion and gastric acid production. They also facilitate basal cell migration towards the 
lumen for repairing the mucosa and maintaining the integrity of nonglandular and glandular 
10 
 
mucosa; this takes place by stimulation of active surface-protecting phospholipid production 
(Andrews & Nadeau, 1999; Murray, 2010; Murray, Schusser, Pipers, & Gross, 1996).  
 
5. Pathophysiology of ESGD and EGGD 
Gastric ulceration occurs whenever there is an increase in acid exposure (pH <4). Squamous 
ulceration occurs rapidly due to minimal defences and reflects increased mobility of acidic 
gastric fluid, while glandular ulceration forms more slowly after the breakdown of the mucous 
and bicarbonate barrier (Hepburn, 2011). 
In short, as discussed previously, there are three types of EGUS: (1) primary squamous 
ulceration, (2) primary glandular ulceration, and (3) secondary squamous ulceration (Sykes & 
Jokisalo, 2014). Primary squamous ulceration occurs when increased acid exposure arises due 
to a change in the normal gastric pH gradient and content stratification.  The primary glandular 
ulceration is defined when acid exposure occurs due to a failure of the mucosal defences. 
Finally, the secondary squamous ulceration, in which delayed gastric emptying (typically pyloric 
disease) increases the residual gastric fluid volume and, later, results in dorsal movement of 
acid (Sykes, Hewetson, et al., 2015). 
 
5.1. Equine Squamous Gastric Disease (ESGD) 
The pathogenesis of ESGD is well described as a result of increased exposure of tissue with 
limited defence mechanisms to highly acidic gastric contents (pH of <4) (Lorenzo-Figueras & 
Merritt, 2002). Any disruption of the normal stratification of gastric pH results in an increased risk 
of ESGD (Lorenzo-Figueras & Merritt, 2002). Mucosal injury was identified within 30 minutes of 
exposure to solutions of hydrochloric acid using in vitro models (Nadeau et al., 2003; 
Widenhouse, Lester & Merritt, 2002). Other known factors considered to contribute to the 
development of the disease are volatile fatty acids (acetic, butyric and propionic acids), the by-
products of carbohydrate fermentation by gastric bacteria (Andrews, Buchanan, Smith, Elliott & 
Saxton, 2006; Nadeau et al., 2003), associated with grain feeding (Luthersson, Hou Nielsen, 
Harris & Parkin, 2009a). Also, a longer carbon chained fatty acid (5 carbons), known as valeric 
acid, was found to have a more profound effect on function of the nonglandular mucosal barrier 
and is thought to be the reason that some cases of ESGD persist despite adequate acid control 
(Andrews, Buchanan, et al., 2006). 
Concentrations of duodenal bile salts may also play a part and can be found in the gastric 
contents of horses deprived of feed for as little as 14 h (Berschneider, Blikslager, & Roberts, 
2010). 
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Numerous studies (MacAllister et al., 1999; Sykes, 2019; Sykes, Sykes, et al., 2014d; Sykes, 
Underwood, Greer, McGowan, & Mills, 2017; Sykes, Underwood, McGowan, & Mills, 2015) 
demonstrated evidence of ESGD healing with effective antacid omeprazole therapy, in the 
absence of risk factor reduction. Therefore, there is a clear indication that gastric acid is the 
foremost erosive agent and that the role of short-chain fatty acids and duodenal bile salts are 
likely to be less critical (Sykes and Jokisalo, 2015). 
Exercise and the increase in intra-abdominal pressure are considered an essential factor in the 
disruption of the pH gradient (Lorenzo-Figueras & Merritt, 2002). 
Feed deprivation has also been shown to cause ulcers in the squamous mucosa of horses 
(Murray, 1994), which is due to repeated exposure of the squamous mucosa to high acidity 
(Murray, 2010). 
Various experimental and epidemiological studies have identified risk factors, while focusing 
primarily on feeding and exercise practices, for ESGD which influence the management of 
clinical cases (Bell, Kingston, Mogg, & Perkins, 2007; Dionne, Vrins, Doucet, & Paré, 2003; 
Husted, Sanchez, Baptiste, & Olsen, 2009; Husted et al., 2008; Luthersson et al., 2009a; 
Pedersen, 2017). 
 
5.2. Equine Glandular Gastric Disease (EGGD) 
The pathogenesis of EGGD has not yet been identified (Sykes, Hewetson, et al., 2015). The 
normal physiological conditions of glandular mucosa are to be exposed to extremely acidic 
gastric contents with the pH in the ventral portion of the stomach fairly stable at around 3 
(Husted et al., 2008). Thus, it is believed that EGGD results from a failure of the normal defence 
mechanisms that protect the mucosa from acidic gastric contents (Sykes and Jokisalo 2015). 
Moreover, the glandular mucosae anatomy and physiology differs according to the different 
regions (pyloric, fundic and cardiac regions) and the response to treatment is likely to be 
different between these regions (Rendle et al., 2018). 
The factors believed to have a role in the disruption of the defence mechanisms in horses are 
bacterial agents and nonsteroidal anti-inflammatory drugs (NSAIDs), which are the predominant 
causes of gastric ulceration in man (Malfertheiner et al, 2009), and will be discussed further in 
more detail. 
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6. Prevalence  
The prevalence of gastric ulceration varies between ESGD and EGGD and according to breed, 
purpose or level of training (Sykes, Hewetson, et al., 2015).  
The high-risk horse populations have been the main focus of many authors over the last years, 
such as racehorses in training, which revealed the highest prevalence of between 80 and 100% 
within the squamous mucosa (Bell, Kingston, Mogg, et al., 2007; Habershon-Butcher et al., 
2012; Hammond, Mason, & Watkins, 1986; Rabuffo et al., 2002; Roy, Vrins, Beauchamp, & 
Doucet, 2005; Vatistas, Snyder, Carlson, et al., 1999). Other horse populations were shown to 
also be at risk, reaching between 40 and 58%, such as endurance horses (Nieto et al., 2004; 
Tamzali et al., 2011), show horses (McClure, Glickman, & Glickman, 1999; Murray et al., 1989) 
and elite western performance horses (Bertone, 2000). 
The prevalence of EGGD is less well described than ESGD (Sykes and Jokisalo, 2015), but it 
has been reported in several studies, ranging from 8% (Sykes and Jokisalo 2015b) to 70% in 
various populations (Sykes, Bowen, Habershon-Butcher, Green, & Hallowell, 2019; Ward, 
Sykes, Brown, Bishop, & Penaluna, 2015). 
 
7. Epidemiology 
Despite the many factors implicated in the cause of EGUS discussed above, several risk factors 
for its development have been identified (Videla & Andrews, 2009). 
While the notion of distinguishing EGGD and ESGD is a somewhat a recent one, the few studies 
that have considered these two syndromes independently found that the risk factors have been 
mostly different. However, the information on risk factors specifically associated with EGGD is 
still lacking (Sykes, Hewetson, et al., 2015). 
Nevertheless, the generally known risk factors for EGUS (not differentiating EGGD and ESGD) 
are intense exercise (Lorenzo-Figueras & Merritt, 2002; Nieto et al. 2004), a high grain-low 
roughage diet (Luthersson et al., 2009; Nadeau et al., 2000), water deprivation (Luthersson et 
al., 2009a), feed deprivation (Husted et al., 2009; Murray & Eichorn, 1996), hospitalization, and 
use of NSAIDs (MacAllister, Morgan, Borne, & Pollet, 1993; Rabuffo, Hackett, Grenager, Boston, 
& Orsini, 2009). Other risk factors include stress, transportation (McClure, White, et al., 2005), 
stall confinement (Bell, Mogg, et al., 2007; Murray & Eichorn, 1996) and the administration of 
hypertonic electrolytes (Holbrook, Simmons, Payton, & MacAllister, 2005). 
Development of EGUS can be as brisk as arising within seven days in some studies (MacAllister 
et al., 1999; McClure, White, et al., 2005) and the risk of disease increases with time in work 
(Habershon-Butcher et al., 2012). 
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7.1. Intrinsic factors: age, gender, temperament and breed 
Results suggesting a higher susceptibility towards developing EGUS due to intrinsic factors such 
as gender, breed, age, and temperament remains debatable (Martínez & Silveira, 2013).  
Different associations have been suggested between the age of the horse and the prevalence of 
gastric ulceration. Vatistas et al. (1999) found that the incidence of gastric ulceration was lowest 
in 2-year-old horses (70%) and highest in 6-year-old horses (100%). In other studies (Murray et 
al., 1996; Orsini, Hackett, & Grenager, 2009; Rabuffo et al., 2002), despite little association 
between age and prevalence of ulcers, there was a significant association between age and 
severity of ulcers, where young horses (2-year-olds) had the lowest mean ulcer scores, 
compared with older horses. Several authors (Bell, Kingston, Mogg, et al., 2007; Dionne et al., 
2003; Roy et al., 2005) stated that the presence or severity of ulceration did not vary significantly 
with the horse’s age or location within the stomach. On the other hand, Luthersson et al. (2009b) 
found evidence of older horses being more prone to have lesions in both the glandular and 
nonglandular regions despite not presenting a higher risk of developing clinically significant 
EGUS. 
In various published studies (Bell, Kingston, Mogg, et al., 2007; Cate, Nielsen, Spooner, 
O’Connor-Robison, & Schott II, 2012; Dionne et al., 2003; Marqués et al., 2011), sex did not 
arise as a significant risk factor for gastric ulceration in active racehorses. A few studies (Rabuffo 
et al., 2002; Vatistas, Snyder, Carlson, et al., 1999) distinguish between castrated and sexually 
intact males, rather than grouping stallions, colts, and geldings together as males, describing a 
higher prevalence in geldings. The cause of these findings is thought to associated with a 
decrease in salivary epidermal growth factor concentration, stimulated by reproductive 
hormones (Rabuffo et al., 2002). Another study (Chameroy et al., 2006) reported the opposite, 
where the majority of horses were mare. 
McClure et al. (1999) conducted a prevalence study on show-horses which identified the horses' 
temperament as a possible risk factor, where horses with a nervous character were more likely 
to have ulceration than quiet or behaviourally normal horses whereas Jonsson and Egenvall 
(2006) found no influence of temperament over gastric ulceration scores. In a more recent study 
(Malmkvist et al., 2012), horses with severe glandular ulcers were found to have a higher stress 
hormone response to novelty, hence more stress sensitive. 
Regarding the importance of breed, as previously mentioned, most prevalence studies of gastric 
ulceration in adult horses have been conducted on Thoroughbreds with the highest incidence, 
and less on Standardbreds (Begg & O’sullivan, 2003; Dionne et al. 2003; Jonsson & Egenvall, 
2006; Luthersson et al., 2009b, 2009a).  Both breeds of racehorses are submitted to demanding 
training requirements and management; however, genetic, behavioural, and gait differences 
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should be considered (Dionne et al., 2003). Warmbloods were also found to be predisposed to 
EGGD with a moderate prevalence, along with increased risk associated with multiple 
handlers/riders (Mönki, Hewetson, & Virtala, 2016).    
Prevalence studies on endurance horses are less frequent then racehorses, nevertheless no 
relationship has been found to date between age, breed or gender on gastric ulcer scores 
(Tamzali et al., 2011). 
 
7.2. Intense exercise 
Once initiating training, several management changes are enforced upon horses, many of which 
have been proven to increase the risk of EGUS, one of which includes exercise (Vatistas, 
Snyder, Carlson, et al., 1999).  
There are still many contradictory results regarding exercise as a possible risk factor of gastric 
ulceration. Luthersson et al. (2009a) found no relationship between the level of exercise and 
EGUS. Numerous other studies conducted in racehorses (Bezděková, Jahn, Vyskočil, & Plachý, 
2005; Murray et al., 1996; Orsini et al., 2009; Roy et al., 2005; Sykes et al., 2019) have been 
comparable with results reported by Hammond et al. (1986), which show that an increase of 
prevalence and lesion grades of specific anatomical lesion sites within the squamous mucosa 
were significantly associated with the increasing intensity of long-duration training. Evidence 
showed that horses in light to heavy training for as short as eight days were at risk of developing 
gastric ulcers (White et al., 2007). 
However, Roy et al. (2005) suggested that seasonality may also have been an influencing factor 
on EGUS prevalence results because horses did not have access to pasture nor free access to 
pasture throughout the study period, which has been reported to decrease the prevalence of 
squamous ulcers in horses. On the other hand, another publication reports a high prevalence of 
EGUS in reproductive mares kept in pasture (Le Jeune, Nieto, Dechant, & Snyder, 2009). 
There are several proposed mechanisms in order to explain the influence of exercise in the 
development of EGUS. The best described is the previously mentioned relationship between 
exposure of squamous mucosa to acidic content and training, demonstrated by a study which 
used an intermittent feed deprivation model (Murray, Eichorn, & Jeffrey, 2001). The acidic 
gastric contents are pushed dorsally into the squamous portion of the stomach by increased 
intra-abdominal pressure and gastric compression associated with gaits faster than walk 
(Lorenzo-Figueras & Merritt, 2002). McClure et al. (2005) suggested that the tensing of 
abdominal muscles may also occur during any other activity that is typical in recreational use of 
horses, such as trailer transport, and ESGD can develop within five days. This process is 
heightened by the fact that physical stress, hence intensive training, has been found associated 
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with an increase in gastrin plasmatic concentration, which promotes glandular secretion of HCl 
production within the gastric lumen (Furr, Taylor, & Kronfeld, 1994; Mills, 1996), thus 
predisposing the mucosa to acid damage (Mönki et al., 2016).  
Authors (Vatistas, Snyder, Carlson, et al., 1999) have also proposed that horses may become 
excited before a race, which could yet again decrease the gastric pH. Another possible cause is 
that before any event horses are feed deprived, which could induce a loss of buffering effect by 
reducing feed content and therefore increase acidity in the stomach (Vatistas, Snyder, Carlson, 
et al., 1999). Squamous ulceration may occur secondary to delayed gastric emptying, caused by 
lesions within the distal stomach and/or duodenum, which cause abnormal reflux of acidic 
contents into the proximal stomach (Merritt, 2012). Lorenzo-Figueras and Merritt (2002) also 
described a decrease in saliva secretion during exercise, which usually buffers gastric fluid, thus 
contributing to more prolonged acid exposure.   
 
7.3. Feeding routine (intermittent versus continuous feeding, feed deprivation), water 
deprivation and stall confinement 
Feeding practices, along with stall confinement, have been identified as significant risk factors 
for developing EGUS (Murray & Eichorn, 1996).  
When horses initiate training, they are stabled, fed intermittently, and many times have no 
access to grazing. Grazing causes a constant secretion of saliva and flow of feed material into 
the stomach, having a buffering effect against the constant gastric acid secretion in the horse 
(Murray, Nout, et al., 2001a). 
Vatistas, Snyder, Carlson, et al. (1999) were able to show evidence of the development of 
EGUS in all the horses within 14 days of being stabled and initiating a training regimen.  
It has been suggested that horses in training fed ad libitum may have a lower risk of developing 
gastric ulcers (Husted et al., 2009; Murray, 1994). Though, even when offered with feed ad 
libitum, they may spend less time eating when stabled, which may decrease this important 
salivary buffering mechanism (Buchanan & Andrews, 2003).  
Horses grazing at pasture, in most cases, have shown a decreased prevalence of ESGD 
(Murray & Eichorn, 1996). However, other studies presented conflicting results regarding 
intermittent feed deprivation.  Bell, Kingston, Mogg et al. (2007) reported that pasture turnout did 
not show evidence of having a protective effect. Husted et al. (2008) described a decreased 
proximal gastric pH in horses apparent after as little as four hours of feed deprivation. This result 
was only significant during the day, describing the presence of a nocturnal pH gradient in the fed 
horses. Feeding routines with intervals longer than 6 hours were found to increase the risk of 
nonglandular lesions (grade ≥2/5) by 3.9 times (95% confidence interval = 1.5 – 10.4) in Danish 
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pleasure horses (Luthersson et al., 2009a). Pedersen et al. (2015) showed that horses fed 
forage once daily were at a higher risk of developing ESGD (grade ≥2/4) than horses fed twice 
daily or more repeatedly.  
Conversely, a prevalence study showed that both pastured pregnant and non-pregnant mares 
had a high prevalence of ESGD (Le Jeune et al., 2009). The authors acknowledged the 
hypotheses of grain and hay supplementation of these mares as a possible cause of increased 
gastric VFA concentration and therefore squamous ulceration (Andrews et al., 2017; Nadeau et 
al., 2000). Another assumption to explain the high prevalence of squamous ulcers in these 
pastured mares might have been due to the horses consuming less forage during evening hours 
than during daytime hours, which may result in less saliva production and a low pH environment 
in the proximal stomach (Husted et al., 2008). 
Water deprivation in pasture turnout has also been associated with both ESGD ≥2 and EGGD 
≥2. Despite the number of hours not being a significant factor, the risk increased when a horse is 
deprived of water for 4 hours, without increasing past this period (Luthersson et al., 2009a). 
Water intake is thought to cause dilution of gastric fluid (Andrews, Frank, et al. 2006) and thus 
pH, although the passage of water through the stomach may depend on the nature of the gastric 
contents (Luthersson et al., 2009a).  
 
7.4. Diet type – Starch content and forage type  
Size and composition of complementary grain meal are believed to be a critical factor associated 
with developing ESGD (Andrews et al., 2017; Reese & Andrews, 2009).  
High starch diets are rich in digestible carbohydrates, resulting in higher production of VFA in the 
upper part of the stomach (Nadeau et al., 2000). The extensive fermentation in this area, due to 
a higher dry matter content and a slower mixture of stomach matter and gastric fluid, associated 
to higher lactic acid production in the lower gastric layers, causes a rapid decrease in gastric 
fluid pH (Harris, Coenen, Frape, Jeffcott, & Meyer, 2006). This low pH (<4) of gastric matter 
causes acid damage to the nonglandular squamous mucosa (Andrews, Buchanan, et al., 2006; 
Nadeau et al., 2000, 2003), similar to gastroesophageal reflux disease (GERD) in Humans 
(Lorenzo-Figueras & Merritt, 2002). 
Feeding practices of 0,5 kg of grain-based concentrates (40% NSC) per 100 kg bwt have been 
proven to produce in general 20 mmol/l of VFAs concentration in the stomach up to 5 h after 
feeding (Nadeau et al., 2000). The high VFAs concentration leads to a decrease in sodium 
transport accompanied by a loss of tissue resistance and an increase in tissue permeability in 
the squamous mucosa in an in vitro Ussing system (Andrews, Buchanan, et al., 2006). Andrews, 
Buchanan, et al. (2006) reported valeric acid to have the most profound impact on mucosal 
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barrier function in comparison with acetic, propionic, or butyric acids while Nadeau et al. (2000) 
reported 78% of acetic acid out of the VFA in the gastric contents of the horses.  
Luthersson et al. (2009a) emphasised the fact that the grain (starch) volume of starch fed per 
day or per meal, over a certain amount, increased the risk of EGUS ≥2 or NG ≥2. 
Moreover, a high-grain diet resulted in a higher serum gastrin concentration, hormone known to 
stimulate secretion of HCl (Sandin, Skidell, Häggström, & Nilsson, 2000) and, is generally 
ingested quicker in horses with squamous (Malmkvist et al., 2012). Additionally, it may reduce 
hay uptake, restricting the production of buffering saliva (Nadeau et al., 2000, 2003). 
Cereals deliver low levels of calcium (Harris et al., 2006) and, perhaps, other buffering agents, 
therefore, contributing to increased risk (Nadeau et al., 2000). Contrary to feeding alfalfa hay 
with grain, which provides a high calcium content (14.4 mg/g of dry weight) and high 
concentrations of crude protein, contributing with buffering effects on gastric contents (Nadeau 
et al., 2000). 
Another study in horses showed evidence that a high starch-low forage diet increased 
squamous gastric ulcer scores in the horses compared to horses on a low starch diet (Al Jassim, 
McGowan, Andrews, & McGowan, 2008). 
Horses that were fed straw as the only forage also increased the risk of EGUS ≥2 or NG ≥2, 
presumably due to the low protein and calcium content and, thus, lacking the buffering aid 
(Luthersson et al., 2009a). 
 
7.5. Stress 
Stress may be the primary cause of glandular gastric ulcers in foals and horses, and stress 
minimisation could be beneficial in reducing the risk of EGGD in some animals (Sykes et al., 
2019). Authors identified trainer as a risk factor for EGGD (Sykes et al. 2019), which aligns with 
results of a previous Finnish study that identified an increased number of caretakers and riders 
as possible risk factors (Mönki et al., 2016). 
It has been suggested that stress-induced release of endogenous cortisol increases the risk of 
developing gastric ulceration; e.g. stress of parturition in foals and stress of training and 
confinement in horses, by inhibition of prostaglandin synthesis, and therefore a failure in 
mucosal protective factors (Andrews & Nadeau, 1999). Horses with EGGD have augmented 
cortisol response to exogenous ACTH administration (Scheidegger et al., 2017) and were found 
to be more stress sensitive presenting in average a 26% higher cortisol concentration in 
response to novel stimuli (Malmkvist et al., 2012). Still, the authors reported a possible paternal 
influence (three stallions fathering 89%) on the risk of having gastric ulceration, justifying specific 
characteristics such as fearfulness and stress-sensitivity as having a genetic component. 
18 
 
In foals, stress was found to be implicated in the development of gastric glandular lesions but not 
in squamous lesions (Furr, Murray, & Ferguson, 1992).   
The stress of hospitalisation for horses with the complaint of colic and those with non-colic 
complaints may also induce gastric mucosal lesions (Rabuffo et al., 2009). Additionally, as 
previously mentioned, the physical stress of high performance in thoroughbred and 
standardbred racehorses may also play a role in the higher occurrence of gastric ulcers in the 
non-colic patients (Orsini et al., 2009). 
 
7.6. Transportation  
The increase in equestrian sports recently has led to a rapid increase in the transportation of 
horses (Friend, 2001). Activities that are typical in recreational use of horses, besides 
transportation, but also housing off-site, were found to be ulcerogenic, with development of 
squamous lesions within five days under these conditions (McClure, Carithers, et al., 2005).  
The stressful impact of transportation on the horse has been proven by repeated increases in 
plasma cortisol concentrations (Möstl et al., 2009). Additionally, the cortisol concentration during 
transport has been reported to be positively correlated with transport time (Fazio, Medica, 
Aronica, Grasso, & Ferlazzo, 2008). 
The increased risk of EGUS associated with transportation may be associated with temporary 
disturbances in the feed as well as water intake (Luthersson et al., 2009a; Möstl et al., 2009).  
 
7.7. Nonsteroidal anti-inflammatory agents  
The role of NSAIDs in the development of EGGD is also debatable. The NSAIDs are commonly 
used in equine clinical practice to treat acute abdominal pain and chronic inflammatory 
conditions, particularly of the locomotor system (Videla & Andrews, 2009). In most cases, horses 
are given either phenylbutazone or flunixin meglumine intravenously for pain control. These 
agents, especially flunixin meglumine are very effective in decreasing abdominal pain associated 
with acute colic; nevertheless, several side effects have been reported that assigns an increased 
risk associated to their use in horses with EGUS (MacAllister et al., 1993 ). 
Administration of high doses or prolonged treatments of NSAIDs has been proven to be the 
cause of ulcers in the glandular portion of the stomach (MacAllister et al., 1993; Martínez 
Aranzales, Cândido de Andrade, & Silveira Alves, 2015). However, studies where the squamous 
mucosa was the primary focus, the same association was not evident (Hammond et al., 1986; 
McClure et al., 1999; Murray et al., 1989, 1996; Rabuffo et al., 2002; Vatistas, Snyder, Carlson, 
et al., 1999). Therefore, it is still unclear if NSAIDs at therapeutic doses increase the risk of 
EGUS (Rendle et al., 2018).  
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Additionally, colonic ulcers and renal failure are other frequent side effects of these drugs, 
regardless of whether the drugs are administered at therapeutic doses or overdoses in horses 
(Andrews, Reinemeyer, & Longhofer, 2009; MacAllister et al., 1993). 
The generally accepted theory to explain the association between NSAIDs and gastric ulcers is 
cyclooxygenase inhibition, in which conversion of arachidonic acid into prostaglandins is blocked 
(MacAllister et al., 1993; Murray, 2010). Consequently, the physiologic vasodilating effect of 
prostaglandins (in particular PGE2) on the stomach mucosa  which creates a bicarbonate 
buffering complex and diminishes the corrosive effect of hydrochloric acid contained in gastric 
secretions (Andrews & Nadeau, 1999; Morrissey, Bellenger, & Baird, 2008) is inhibited, therefore 
generating the ideal conditions for development of ulcers in the gastrointestinal tract (Andrews & 
Nadeau, 1999; Murray et al., 1996). Martínez Aranzales et al. (2015) described another 
mechanism of injury in the horse stomach, using an EGUS induction model based on a 
phenylbutazone protocol, which showed the ability to induce oxidative stress in glandular 
mucosa of horses by changing the antioxidant-oxidant balance. 
Evidence from laboratory animals supports the hypothesis of decreased prostanoids and 
oxidative stress in gastric alterations caused by NSAIDs in humans (Berenguer, Alarcón de la 
Lastra, Moreno, & Martı́n, 2002; Tomisato et al., 2004). Mitochondrial oxidative phosphorylation 
inhibition in mucus-producing cells was shown to alter the hydrophobic characteristics and 
exhibit direct cytotoxic effects, including necrosis and apoptosis (Tomisato et al., 2004). 
However, only effects dependent on the inhibition of PGs have been previously reported in 
horses (Martínez Aranzales et al., 2015).  
According to Andrews et al. (2005), gastric mucosal ischemia may lead to hypoxia-induced 
cellular acidosis, and release of oxygen-free radicals, phospholipases and proteases, which may 
damage the cell membrane and result in necrosis. Furthermore, the interaction between the 
chemical properties of most NSAIDs and the acidic conditions of the stomach enhances the 
cellular changes in the gastric mucosa (Martínez Aranzales et al., 2015). 
Nonetheless, at clinical doses, phenylbutazone and suxibuzone did not cause gastric ulceration 
when administered during 15 days (Andrews et al., 2009). Neither did a maximum 
recommended dosage of phenylbutazone affect cyclooxygenase-1 or -2 gene expression for 
seven days (Nieto, Aleman, Anderson, Fiack, & Snyder, 2012). Additionally, authors stated the 
administration of NSAIDs was not found to be a probable risk factor for EGUS (Habershon-
Butcher et al., 2012), suggesting the possibility of existing mechanisms other than impaired 
prostaglandin synthesis involved in the formation of glandular gastric ulcers (Pedersen, 2017).  
As such, despite the conflicting evidence regarding the influence of NSAIDs on the development 
of EGUS, the Council considers the high prevalence reported in many populations in need of 
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further investigation and concludes that is unlikely a possible risk factor in the greater number of 
patients (Sykes, Hewetson, et al., 2015). 
 
7.8. Parasites 
Many organisms are known to parasite the equine stomach. Nine species of larvae of flies 
belonging to the genus Gasterophilus (Diptera, Oestridae) are commonly found causing myiasis 
in the gastrointestinal tract of equine (Cogley, 1999). The third larval stage (L3) in all 
Gasterophilus species can remain attached to the gastric mucosa for periods of 8–9 months, 
during which time may cause nonspecific clinical signs characterized by difficulties in 
swallowing, gastrointestinal ulcerations, gastrointestinal obstructions or volvulus, anaemia, 
diarrhoea and many other digestive disorders (Cogley, 1989). Bot larvae were found consistently 
gathered together on the non-glandular mucosa adjacent to the margo plicatus (75%) 
(Agneessens et al. 1998). A. Niedźwiedź, Borowicz, and Nicpoń (2013) detected only 
Gasterophilus intestinalis and Gasterophilus nasalis in 47% of cases in a prevalence study 
conducted in eastern Poland. 
Additionally, gastric habronemosis in horses occurs with a worldwide distribution, caused by 
both adult and larval stages of Habronema microstoma and Habronema muscae (Nematoda, 
Spirurida), transmitted by muscid flies (e.g. Stomoxys calcitrans and Musca domestica) 
(Anderson, 2000). Habronema spp. inhabit either in the stomach wall or on the mucosal surface 
near to the margo plicatus, the fundus or the pyloric valve, causing chronic catarrhal gastritis 
with symptoms of varying degrees of severity, such as anorexia, digestive disorders, diarrhoea, 
progressive weight loss, ulcers and postprandial colics (Anderson, 2000; Traversa et al., 2006). 
Fernandes, Belli, and Silva (2003) reported a high occurrence of Habronema spp. (28.6%) 
mainly in the region of the margo plicatus in horses with chronic catarrhal gastritis while 
Traversa et al. (2006) reported a prevalence infection by Habronema spp. of 53,6%.  
Recently, Cardona, Álvarez, and Paredes (2016) found a significative association between the 
high occurrence of cavitary gastric myiasis with the severity degree of squamous ulcers 
secondary to abnormal gastric emptying.  
Nonetheless, there were authors (Chameroy et al., 2006) who stated the absence of parasites 
on examinations of horses with gastric ulcers. Nadeau and Andrews (2009) considered that the 
parasites did not play a substantial role in the development of ulcers, because only 9 out of 169 
racehorses in one study presented parasites in the stomach at the examination.  
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7.9. Bacteria 
The function of bacteria in the pathogenesis of EGGD is controversial. Helicobacter pylori are 
commonly implicated for the onset of gastritis and PUD in man (Collier & Stoneham, 1997; 
Malfertheiner et al., 2009). Although many species of Helicobacter have been identified and 
associated with ulcers and non-ulcerative gastritis in other animals (Fox, 2002), Helicobacter 
pylori and other Helicobacter spp. have not been proven to cause EGGD or ESGD in horses 
(Rendle et al., 2018). 
Numerous attempts have been made to explain the microbial aetiology of EGGD remaining still 
conflicting results. Belli et al. (2003) reported identifying urease enzyme in a gastric sample from 
one horse examined suffering from gastric lesions, suggesting the presence of Helicobacter 
urease-positive species. Morales, Garcia, and Bermudez (2010) stated that thirty-eight per cent 
(n=52/136) of the horses infected by Helicobacter examined showed gastric mucosal lesions, 
and all horses with Helicobacter were urease positive. Furthermore, two pieces of research 
identified Helicobacter specific-DNA from the squamous and glandular mucosa of horses, 
thought to be less pathogenic than the human form, demanding still further studies on the 
matter. Hepburn (2004) identified Helicobacter genus-specific DNA by PCR in biopsy samples of 
asymptomatic horses, having found grade 1/2 glandular ulceration in 42% of horses. Contreras 
et al. (2007) detected Helicobacter-like DNA in the gastric mucosa of asymptomatic 
Thoroughbred horses, even though H. pylori-specific PCR detection was unsuccessful.  
Additionally, a new enterohepatic Helicobacter species were isolated from faecal samples of two 
clinically healthy horses - Helicobacter equorum (Hilde Moyaert et al., 2007). H. Moyaert, 
Haesebrouck, et al. (2007) then determined a low zoonotic potential of H. equorum, reinforcing 
the need for more research on the newly discovered organism. 
These bacteria were found colonising the distal gastrointestinal tract (H. Moyaert, Decostere, et 
al., 2007). This finding, along with Bezdekova and Futas (2009) negative results for H. equorum 
DNA detection from gastric biopsies in horses, confirmed that any possible role of this species in 
EGUS etiopathogenesis should be excluded.  
The microbial composition and balance within the stomach have been theorised to be related to 
the development of EGGD (Vatistas, Snyder, Carlson, et al., 1999), although there was no 
significant difference between the microbiota of horses with EGGD and healthy horses in two 
different studies (Dong et al., 2016; Perkins et al., 2012).  
Nonetheless, several studies have failed to identify Helicobacter organisms in association with 
ulcers in horses (Husted, Jensen, Olsen, & Mølbak, 2010; Martineau, Thompson, & Taylor, 
2009).  
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Evidence was found of involvement of a diverse mucosal bacteria population consisting of 
Lactobacillus and Streptococcus species and Escherichia coli in the pathogenesis of gastric 
ulceration, and the importance of modification of this population for future treatment outcome (Al 
Jassim et al., 2008). Authors reported information that corroborated with both gastric-adapted 
bacteria and opportunistic pathogens possible role in squamous ulceration (Al Jassim et al., 
2008) but whether the situation is similar in the glandular mucosa is unknown. 
Overall, based on the weak historical evidence of Helicobacter infection in association with 
ulcers in horses, indicates that Helicobacter spp. are possibly not a prevalent asymptomatic 
inhabitant of the equine stomach, and their function in gastric ulceration in the horse is until now 
to be determined (Perkins et al., 2012). Helicobacter pylori is believed to be an unlikely primary 
contributing factor in the development of EGGD (Perkins et al., 2012; Rendle et al., 2018; Sykes, 
Hewetson, et al., 2015; Sykes & Jokisalo, 2015) although certain species may have the capacity 
to colonize the damaged mucosa and prevent healing (Rendle et al., 2018). Also, the role of 
secondary bacterial infection has not been sufficiently established to justify the general use of 
antimicrobials in the treatment of EGUS (Sykes & Jokisalo, 2015) 
 
8. Clinical signs of EGUS 
Gastric ulceration can cause a wide variety of clinical signs, such as abdominal discomfort, colic, 
lack of appetite, poor body condition and weight loss, dullness of coat, decrease in performance, 
diarrhoea, and stereotypic behaviour (Collier & Stoneham, 1997; Murray et al., 1989; Sandin et 
al., 2000; Vatistas, Snyder, Carlson, et al., 1999). Other signs may include, particularly in foals, a 
loss of vitality, dorsal recumbency, and bruxism (Nadeau & Andrews, 2009; Sandin et al., 2000; 
Vatistas, Snyder, Carlson, et al., 1999). 
Unfortunately, these clinical signs are non-specific, and horses presenting with clinical signs 
suggestive of EGUS may have no gastroscopic evidence of gastric ulceration. A Swedish study 
of 80 Standardbred racehorses, trained by nine different trainers, suggested that changes in 
performance, behaviour, and eating habits provided only weak clues that an individual horse 
might have EGUS (Jonsson & Egenvall, 2006). Dionne et al. (2003) suggested that a poor body 
condition was the only clinical sign distinctly associated with the presence of gastric ulcers and 
high lesion scores in Standardbreds, whereas recent studies failed to confirm this cause-and-
effect relationship (Cate et al., 2012; Poulsen, Sondergaard, Luthersson, & Malmkvist, 2011). 
Poulsen et al. (2011) also suggested that a history of eating slowly, which is believed to be 
associated to a lack of appetite, cannot be assumed as a sign that ulcers are present. 
Decreased performance is a commonly referred complaint in racehorses with suspected EGUS 
(Bell, Mogg, et al., 2007; Franklin, Brazil, & Allen, 2008). However, Cate et al. (2012) ran a study 
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where trainers assessed the horses' performance as to predict the presence of gastric ulcers 
using an ordinal scale, which presented many limitations and failed to do so. The authors, 
however, were not surprised with the results, pointing to the fact that performance can be 
influenced by many other factors such as physical ability, mental state, and soundness.  
Crib-biting and other types of abnormal behaviour have been identified as a sign of frustration 
and/or stress in situations with stimulation, such as feeding periods (Nagy, Bodó, Bárdos, 
Harnos, & Kabai, 2009). However, Malmkvist et al. (2012) failed to demonstrate an association 
between traditional abnormal behaviour (crib-biting, weaving), excessive licking, and glandular 
ulceration in adult horses. Wickens et al. (2013) found no significant differences in the ulcer 
scores, the prevalence of hyperkeratosis, or baseline gastric pH between crib-biting horses and 
non-crib-biting horses. Though, the serum gastrin concentration at 60 and 120 minutes was 
greater (P <.05) and tended to be higher (P <.06), respectively, in CB than in NCB horses 
following concentrate feeding, which possibly led to a greater increase in gastric acid secretion. 
Nonetheless, stomachs from CB horses do not differ anatomically nor physiologically from NCB 
horses and are rather a clinical response to environmental and cellular stress (Daniels, Scott, De 
Lavis, Linekar, & Hemmings, 2018). 
Horses with simple obstruction or ulceration often present mild, intermittent abdominal pain that 
often resolves with appropriate medical treatment (Moore, 2006). Gastric ulceration was found in 
68% (n=76/112) of horses with a history of recurrent episodes of abdominal pain, and 72% of 
horses with non-colic complaints (Rabuffo et al., 2009). In this report, Rabuffo et al. (2009) 
referred gastric ulceration as the sole complaint in only 12% (13/112), whereas nearly 28% 
(31/111) of horses in Murray’s study had gastric ulceration as the primary cause of colic (Murray 
1992). Also, Dukti et al. (2010) reported results which showed that fewer horses presented to a 
referral hospital for surgically-managed colic (32%) had gastric ulcers than horses that 
presented for medically-managed colic (49%).   
However, none of the reports cited determined whether the severity of clinical signs correlated 
with the severity, number or location of gastric ulcers. 
Even so, studies have reported a large number of asymptomatic horses with gastric ulcerations 
(Cate et al., 2012; Fernandes et al., 2003; Malmkvist et al., 2012; Niedźwiedź, Kubiak, & Nicpoń, 
2013) which reinforces the importance of random sampling to achieve an accurate estimate of 
the prevalence of EGUS in a population (Bell, Kingston, Mogg et al., 2007).  
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9. Diagnosis of EGUS 
Diagnosis of EGUS is complicated since the clinical signs demonstrated by the horse are 
nonspecific, as discussed above. Gastroscopy is considered the only steady antemortem 
method for precise identification of gastric ulceration in the horse (Bell, Mogg, et al., 2007; 
Sykes, Hewetson, et al., 2015). However, a detailed clinical history, a systematic physical 
examination and the identification of risk factors that may be associated in each case can help 
predict the presence of gastric ulceration (Reese & Andrews, 2009). 
In the absence of gastroscopy, empiric treatment may be employed, to use the response to 
treatment as a means of indirectly diagnosing EGUS (Bell, Mogg, et al., 2007). Though, given 
the high cost of treatment and the importance of distinguishing ESGD from EGGD, the initiation 
of treatment without previous gastroscopy is not recommended (Sykes, Hewetson, et al., 2015). 
In cases where empirical treatment is attempted, and the horse does not respond to treatment, 
gastroscopy should still be carried out to definitively eliminate the gastric disease as a suspicion, 
as some animals maintain the clinical complaints while complete healing of lesions has not 
occurred. 
 
9.1. Blood analysis - haematological and biochemical changes  
There are currently no consistent haematological or biomechanical markers available to support 
in the diagnosis of gastric ulceration. Although, show horses with chronic gastric ulceration were 
found to have anaemia and hypoalbuminaemia (McClure et al., 1999; Reese & Andrews, 2009). 
Still, according to Videla and Andrews (2009), despite the low erythrocyte number and 
haemoglobin concentration, they are hardly ever lower than the limits of reference values. 
Another study conducted by Dezfouli et al. (2009) in Persian Arab horses stated a decrease in 
the number of monocytes and increased potassium concentration in horses with EGUS.  Cate et 
al. (2012) failed to determine the existence of gastric bleeding ulcers by evaluating packed cell 
volume (PCV) and total solids confirming the inexistence of pathognomonic clinical signs for 
EGUS and reinforcing the importance of a complete endoscopic examination for a clinical 
diagnosis. 
Recently, investigators identified ten serum proteins, using electrophoresis and mass 
spectrometry, which may be used as presumed markers for ESGD, though future investigation is 
required to fully comprehend the role and association of these proteins to ESGD (Tesena et al., 
2019). 
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9.2. Faecal occult blood test  
Horses may manifest melena as a clinical sign suggestive of gastric ulceration. Therefore, a 
guaiac acid-based faecal occult blood test has been found to improve both the accuracy and 
speed of diagnosis of EGUS (Pellegrini, 2005). Though, results of this test indicate a poor 
sensitivity, low specificity and predisposition for interference, with a positive predictive value of 
90% and a negative predictive value of only 17%. In order to improve the negative predictive 
value of the FOBT, investigators developed another test (Succeed® Equine Faecal Blood 
Test™, Freedom Health LLC1) that uses specific equine monoclonal antibodies to both albumin 
and haemoglobin in an easy-to-use kit (Freedom Health LLC 2011). Recently, the Succeed® 
test which is currently on the market has been tested for its diagnostic accuracy against 
gastroscopy in a population of Thoroughbred racehorses and demonstrated high specificity and 
low sensitivity and high false-negative results for the diagnosis of EGUS (Sykes, Jokisalo, & 
Hallowell, 2014). Therefore, its use to diagnose EGUS is limited but might be a helpful tool to 
diagnose and document healing in horses with another gastrointestinal disease, such as colitis 
(Camacho-Luna, Buchanan, & Andrews, 2018). 
 
9.3. Endoscopic examination 
Gastroscopy is currently considered the gold standard method for antemortem diagnosis and 
monitorization of EGUS (Sykes, Hewetson, et al., 2015). Standing gastroscopy procedures have 
been described in detail in many reports, using scopes of <3m long allowing visualisation of the 
nonglandular mucosa and margo plicatus (Murray, 1992; Murray et al., 1989, 1996). However, 
the gastroscopes cited in the earlier literature are insufficient in length to allow examination of 
the entire stomach in most adult horses (Murray, Nout, et al., 2001b), lacking in particular, the 
examination of the pylorus antrum and proximal duodenum, essential regions where the majority 
of glandular disease occurs (Begg & O’sullivan, 2003; Luthersson et al., 2009b; Tamzali et al., 
2011). Therefore, to overcome this limitation, a relatively simple clinical procedure has been 
described which recommends the use of scopes with an insertion length of at least 3 m and an 
outer diameter of approximately 12.8 mm to (Sykes & Jokisalo, 2014).  
Case preparation prior examination is necessary to allow the best visibility and facilitate the entry 
into the pyloric antrum. The required fasting period may be dependent on the horse’s use and 
diet, ranging from a minimum of 6-8 hours to 16 hours (Sykes, Sykes, & Hallowell, 2014b).  
Nonetheless, the owner/trainer is told to feed the horse their normal grain meal while only a 
 
1Freedom Health LLC, 65 Aurora Industrial Pkwy, Aurora, OH 44202, EUA. 
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small amount of hay the night before and to remove all remaining feed first thing in the morning 
(Sykes & Jokisalo, 2014).  
Generally, horses are given moderate sedation with an alpha-2 agonist and tolerate the 
procedure very well. The endoscope is introduced via one nostril, progresses through the 
oesophagus until it reaches the stomach. The main areas of examination are the greater 
curvature, the lesser curvature and the pyloric antrum (Sykes & Jokisalo, 2014).  
When severe pathological changes are suspected or if cases are refractory to treatment for 3 or 
more months then transendoscopic biopsies associated to the gastroscopy procedure should be 
considered; otherwise, biopsies are seldom indicated (Rendle et al., 2018). 
 
9.3.1. Scoring system for gastric ulcers in the horse 
Lesions visualised using gastroscopy should be subjectively graded according to their number 
and severity. Ideally, objective measurements of the size and depth of the lesions should be 
taken as a factor of severity, yet ambitious due to the irregularity of the lesions (Macallister, 
Andrews, Deegan, Ruoff & Olovson, 1997).  
Many different scoring systems have been published over the years, and the lack of 
standardised scoring system restricts the clinical case comparison between different prevalence 
studies (Bell, Mogg, & Kingston, 2007; Collier & Stoneham, 1997). The reported scoring systems 
vary from a 0-3 scale reported by MacAllister (Dionne et al., 2003; MacAllister et al., 1999; 
Vatistas, Snyder, Carlson, et al., 1999),  0-4 (Andrews et al., 2002; Furr & Murray, 1989), 0-5 
((Bell, Kingston, & Mogg, 2007; Vatistas, Snyder, Nieto, et al., 1999), 0-6 (McClure et al., 1999) 
and even 0-10 (Murray & Eichorn, 1996). The assortment of scoring systems described in the 
literature is such that even separate studies by the same investigators have used different 
scoring systems (Murray & Eichorn, 1996; Murray et al., 1989, 1996; Vatistas, Snyder, Carlson, 
et al., 1999; Vatistas, Snyder, Nieto, et al., 1999). A study by Bell et al. (2007) showed that the 
generally used 0-4 scale was repeatable and reliable between operators and was also more 
accessible and faster than the Number/Severity scoring system reported by MacAllister et al. 
(1997). 
Opportunely, in recent years, the European College of Equine Internal Medicine recommended 
the use of a standard, easy and accurate scoring system in a consensus statement (Sykes, 
Hewetson, et al., 2015). 
Endoscopic grading of ulcers, even though not foolproof, offers a foundation for severity scoring 
and monitoring response to treatment (Pedersen, 2017). 
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9.3.2. Complications and disadvantages 
The technique of gastroscopic examination is quite unambiguous, although, in order to reach a 
complete examination of the stomach, it requires a certain level of expertise to perform and 
interpret (Sykes & Jokisalo, 2014). Disadvantages of endoscopic examination include the 
condition of the horse to be sedated, it is not promptly available to most clinicians, and it is an 
inefficient expenditure of time.  
Additionally, complications may occur during the procedure. Although rare, oesophagal rupture 
may occur due to iatrogenic perforation during repeated nasogastric tube insertion (or scope), 
which can be fatal (Bezdekova, 2012). Also, if the gastroscope is removed without removing the 
air from the stomach, due to the characteristics of the horse’s cardia sphincter, the only way to 
expel it will be gradually through the pylorus (Kihurani, Carstens, Saulez, & Donnellan, 2009). 
Thus, removal of the air by suction is recommended at the end of the procedure, since gastric 
distension increases the risk of colic (Sykes, Hewetson, et al., 2015). 
 
9.4. Other diagnostic methods 
A sucrose permeability test has shown the potential for non-invasive detection of gastric ulcers 
as a simple and economical alternative to gastroscopy for screening purposes (Hewetson et al.,  
2006; O’Conner et al., 2004). However, this method involves sophisticated equipment and 
therefore, may not be available in clinical practice (Reese & Andrews, 2009).  
Nonetheless, in recent publications, results showed that blood sucrose was neither a sensitive 
nor specific test for detecting EGUS in mature horses, therefore inept as a screening test for 
EGUS nor will it be expectable to replace gastroscopy in this study population (Hewetson, 2018; 
Hewetson et al., 2018). In contrast, the same studies concluded that blood sucrose seems to be 
a sensitive test for detecting EGUS in foals and may represent a clinically useful screening test 
to identify foals that may benefit from gastroscopy.  
 
10. Management of EGUS 
10.1. Pharmacological treatment 
The purpose of EGUS therapy is to eliminate clinical signs, promote the healing of lesions and 
prevent a recurrence. Thus, the primary strategy is to increase gastric pH by suppressing HCL 
secretion (MacAllister et al., 1999). Several treatments have been promoted for the management 
of both ESGD and EGGD. Evidence for the relative efficacy of acid suppression treatment to 
reduce the prevalence and promote healing of gastric ulcers in horses is well documented for 
ESGD, though limited for EGGD. Although EGGD is improbable to be caused solely by acid 
injury, acid suppression is still recommended regardless of failure to identify an underlying 
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cause, as it is considered essential for mucosal repair but a longer treatment period may be vital 
(Sykes, Hewetson, et al., 2015). 
Nonetheless, gastric ulcers often heal without medical intervention, and authors have theorised 
that medications that reduce gastric acidity do not initiate healing, but rather facilitate ulcer 
healing by providing a microenvironment that is optimal for healing to proceed (Murray, Eichorn, 
et al., 2001). 
 
10.1.1. Proton pump inhibitors 
10.1.1.1. Omeprazole  
➢ Pharmacokinetics 
Oral omeprazole, a substituted benzimidazole, is the preferred drug for the prevention and 
treatment of EGUS associated with the squamous mucosa (Sykes, 2019). It is absorbed in the 
small intestine and acts systemically as a proton pump inhibitor, binding irreversibly to the 
hydrogen/potassium adenosine triphosphatase (H+/K+ ATPase) enzyme system on the secretory 
surface of parietal cells, blocking it and therefore inhibiting gastric acid secretion and increasing 
gastric pH (Hepburn, 2011; Mason, Moroney, & Mason, 2019; McClure, White, et al., 2005).  
As an acid labile crystalline powder, it is quickly degraded in the acid environment during its 
passage through the stomach. The remaining intact fraction of omeprazole is then absorbed in 
the small intestine and afterwards transported via the bloodstream to the basal side of the 
parietal cells where it exerts its effect (Andrews, Sifferman, et al., 1999; MacAllister et al., 1999; 
Nieto et al., 2002). 
 
➢ Presentation 
Omeprazole is used in an enteric-coated encapsulated formulation in humans, available in the 
form of granules of 10, 20 or 40mg (Prontuário terapêutico on-line 2019) or in the form of a 
specific oral powder paste formulation for horses (e.g. GastroGard®, Boehringer Ingelheim2), is 
that each dose-adjustable syringe contains 2.28g of Omeprazole (Direção Geral de Alimentação 
e Veterinária 2018).  
In order to increase acid stability of this acid labile drug, it has been recommended that the 
formulation requires the incorporation of some form of protection because exposure to acid in 
the stomach followed by alkalinisation in the small intestine causes the drug to become inactive 
before absorption can occur (Merritt, Sanchez, Burrow, Church, & Ludzia, 2003). Thus, most 
commercial products are formulated to include buffering with a highly alkaline medium, or the 
 
2 Boehringer Ingelheim Animal Health Portugal Unipessoal Lda., Av. de Pádua, nº 11 1800-294 Lisboa. 
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use of enteric-coated granules suspended in a paste (Sykes, Underwood, Greer, & Mills, 2015). 
The encapsulated formulation used in humans protects the agent during the passage through 
the acidic environment in the stomach, then once it reaches the alkaline setting of the small 
intestine, the acid-stable coating is degraded and the active ingredients are released (Haven et 
al., 2010; Nieto et al., 2002). In a recent study, Sykes, Underwood, McGowan, et al. (2015) 
reported the bioavailability of an enteric-coated granule formulation (Gastrozol®, Virbac3) to be 
nearly twice that of a plain, unprotected oral omeprazole (Sykes, Underwood, McGowan, et al., 
2015) supporting this recommendation.  
The efficacies of the different methods of protection are, however poorly investigated to date. 
Nonetheless, studies have shown that the method of protection, either enteric coating or 
buffering of the formulation, appears to have no effect on pharmacokinetics (Birkmann, Junge, 
Maischberger, Wehrli Eser, & Schwarzwald, 2014; Sykes, Underwood, Greer, et al., 2015). 
Authors stated that dose linear pharmacokinetics had not been demonstrated for omeprazole in 
the horse, and therefore it cannot be assumed that the pharmacokinetics of the two doses are 
equivalent, and the direct comparison of different doses is not appropriate (Sykes, Underwood, 
McGowan, et al., 2015). 
Due to the relatively high cost of GastroGard® (Merial4), some veterinary physicians choose to 
prescribe cheaper magistral preparations of omeprazole that are formulated in several private 
pharmacies, or even opt for preparations available for Human medicine (Merritt et al., 2003).  
Intravenous administration of omeprazole is another option in the treatment of SUGE in cases 
displaying dysphagia, gastric reflux, or another disease that restricts the oral administration of 
omeprazole in the paste form (Andrews, Frank, et al., 2006; Hepburn, 2011). Despite a fast and 
potent onset of action, authors (Sykes, Underwood, McGowan, et al., 2015) have reported a 
shorter half-life compared to oral formulations. Although not yet available on the market, a recent 
preliminary investigation has been reported on a new, long-acting, injectable, intramuscular 
formulation of omeprazole in the horse (Sykes, Kathawala, et al., 2017). 
 
➢ Dosage 
The oral omeprazole paste, developed for usage in horses, is the most effective formulation with 
the most extensive investigation, initially recommended by the EGUS Council (Andrews et al., 
1999). Reports of administration of the reference dose of  4 mg/kg orally, SID,  significantly 
suppresses gastric acidity for 24 hours, with EGUS healing rates of 77%-86% and significant 
 
3 Virbac (Australia) Pty Ltd, 361 Horsley Road, Milperra NSW 2214. 
4 Merial Ltd., Duluth, Georgia, USA. 
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improvement rates of over 90% (Doucet, Vrins, Dionne, Alva, & Ericsson, 2003; Lester, Smith, & 
Robertson, 2005; MacAllister et al., 1999; McClure, White, et al., 2005; Murray et al., 1997). 
However, based on currently available evidence, the committee suggests that the use of 
buffered formulations at 2 mg/kg PO once daily warrants further review (Sykes et al., 2015). 
Similarly, based on reported studies (Birkmann et al., 2014; Sykes, Sykes, et al., 2015) the use 
of enteric coated granule formulations at 1.0 mg/kg PO, SID, seems acceptable (Sykes, 
Hewetson, et al., 2015). 
Current treatment recommendations are of a minimum of 4 weeks duration (28 days) based 
principally on existing recommendations for ESGD and clinical experience (Sykes, Hewetson, et 
al., 2015). Though, duration of treatment also warrants further consideration, since the duration 
of acid suppression achieved under clinical conditions may be less than initially reported in 
previous experimental studies (Sykes 2019). Recent studies showed that EGGD favourable 
treatment response was only 25%, in opposition to the reported 78% of ESGD favourable 
treatment response at 4 mg/kg bwt per os once a day for 28–35 days (Sykes, Sykes, et al., 
2014d, 2014a, 2015). Given the differences in pathophysiology between ESGD and EGGD, it is 
possible that a longer duration of treatment may be required for EGGD healing to occur (Sykes 
2019). Therefore, it is possible to repeat gastroscopy at either 14, 21 or 28 days. If gastroscopy 
is not accessible, then treatment should be extended for 28 days (Sykes, Sykes, et al., 2014d, 
2014a, 2015). 
Also, factors such as dose and diet can affect oral bioavailability in some horses (Sykes, 
Underwood, Greer, et al., 2015; Sykes, Underwood, McGowan, & Mills, 2015, 2017). Therefore, 
the use of a single dosing recommendation which comprehends all horse types and 
management conditions may not be suitable and dosing recommendations that take into account 
the diet of the horse may be advantageous (Sykes, Underwood, et al., 2017).  
In dysphagic patients, intravenous omeprazole at 1 mg/kg every 24 hours can be used, although 
this represents off-licence use (Hepburn, 2011). 
 
➢ Efficacy 
Various previous reported clinical trials (Andrews, Sifferman, et al., 1999; Doucet et al., 2003; 
McClure, White, et al., 2005; White et al., 2007) have found significant differences in ulcer 
severity between preventive treatment and sham groups, whereas others (Endo et al., 2012; 
Lester et al., 2005) have shown no significant differences. Also, more than 50% of the reported 
clinical trials to date have had a reporting attrition bias (Endo et al., 2012; Lester et al., 2005; 
McClure, White, et al., 2005; Sykes, Sykes, et al., 2014d). 
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Nevertheless, omeprazole has been shown to be efficacious in the short term in numerous 
previous studies (Andrews, Sifferman, et al., 1999; Doucet et al., 2003; Murray et al., 1997; 
Sykes, Sykes, et al., 2014a) with healing rates of 73% to 80% and improvement rates of up to 
92% following 25 to 56 days of treatment. Though, recent studies (Sykes, Sykes, et al., 2014b, 
2014a, 2015) have shown a lower healing rate of EGGD, in which only 25% of glandular ulcers 
healed with 28–35 days of omeprazole therapy at 4.0 mg/kg per os SID, compared to an ESGD 
healing rate of 78%. The reported EGGD healing rates suggest that specific treatment 
recommendations for EGGD are required and that direct extrapolation of ESGD treatment 
recommendations are unsuitable (Sykes & Jokisalo 2015). 
Limited records are available on the relative pharmacokinetics and pharmacodynamics of 
different omeprazole formulations (Sykes, Underwood, McGowan, et al. 2017). However, the 
patent of the formulation predominately used globally - GastroGard (Merial5) has recently 
expired, and interest in different formulations has increased (Birkmann et al., 2014; Sykes & 
Jokisalo, 2015). A recent study compared pharmacokinetic and pharmacodynamic effects of a 
novel omeprazole formulation (Ulcershield: ULS) with a currently registered reference 
omeprazole product (OMO) and found that both formulations were pharmacodynamically 
equivalent, as well as a similar beneficial effect on gastric squamous mucosal ulceration (Raidal, 
Andrews, Nielsen, & Trope, 2017). 
 
10.1.1.2. Esomeprazole 
Esomeprazole, the S enantiomer of omeprazole, is reported more efficacious than omeprazole 
after oral administration in humans (Andersson, Hassan-Alin, Hasselgren, Röhss, & Weidolf, 
2001; Scott, Dunn, Mallarkey, & Sharpe, 2002). 
There is still limited information on the efficacy of esomeprazole in horses. One study showed 
that intravenous (IV) administration of esomeprazole to horses for 14 days significantly 
increased gastric fluid pH (Videla, Sommardahl, Elliott, Vasili, & Andrews, 2011). In a recent 
clinical trial, an enteric coated esomeprazole paste was found equally as effective as 
omeprazole paste in increasing gastric pH in horses and may be a therapeutic alternative 
effective as omeprazole paste in increasing gastric pH in horses (Huxford, Dart, Perkins, Bell, & 
Jeffcott, 2017). 
The improved efficacy of esomeprazole is thought to be caused by a lower plasma clearance 
and larger area under the curve for plasma concentration-time when compared with omeprazole. 
 
5 Merial Ltd., Duluth, Georgia, USA. 
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The higher plasma concentrations give rise to a greater drug availability to inhibit parietal cell 
HCl secretion (Sykes, 2019) 
 
10.1.1.3. Pantoprazole 
Pantoprazole, another proton pump inhibitor, has been reported to significantly increase gastric 
fluid pH after IV (1.5 mg/kg) and intragastric administration (1.5 mg/kg, bwt) in neonatal foals 
(Ryan, Sanchez, Giguère, & Vickroy, 2010).  Authors suggest the use of pantoprazole IV in foals 
with pyloric outflow obstruction, especially since IV administration of ranitidine has shown 
inconsistent effects on increasing gastric fluid pH (Camacho-Luna et al., 2018). However, 
intragastric administration of pantoprazole leads to a lower bioavailability, when compared with 
oral administration of omeprazole, therefore a higher dose should be used if administered orally 
in foals. 
 
10.1.2. Histamine type-2 receptor antagonists 
Histamine type-2 receptor antagonists, such as ranitidine and cimetidine, suppress HCl 
secretion by reversibly binding and competitively blocking the parietal cell H2 receptors and their 
efficacy is dependent on maintaining plasma concentrations of the drug (Camacho-Luna et al., 
2018).  
Buchanan and Andrews (2003) reported that ranitidine requires three times daily oral 
administration and longer treatment duration (45–60 days) compared with omeprazole (28 days) 
to achieve similar healing. Lester et al. (2005) later confirmed that ranitidine was less effective 
than omeprazole in healing ESGD in Thoroughbred racehorses. Cimetidine, however, does not 
seem to be effective in the treatment of EGUS and is not recommended (Sykes & Jokisalo, 
2015). 
 
10.1.3. Coating and binding agents 
The use of mucosal barrier protectants may be useful given the proposed failure of mucosal 
defence mechanisms in the pathogenesis of EGGD (Sykes, 2019). Sucralfate, a polyaluminium 
hydroxide with a sulphated disaccharide structure, adheres to the mucosa and may have several 
positive effects (Rendle et al., 2018). Sucralfate acts as a physical barrier to acid diffusion, 
causes stimulation of mucus secretion, inhibition of pepsin and bile acid release,  promotes re-
epithelialisation by prevention of fibroblast degradation, stimulates epidermal and insulin-like 
growth factors and increases mucosal blood flow through increased production of prostaglandin 
E (PGE) (Rendle et al., 2018).  
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Sucralfate at 12 mg/kg PO BID combined with omeprazole (4 mg/kg PO SID) was recommended 
to treat glandular ulcers with a reported 80% improvement and 63% healing rates of grades ≥2 
EGGD lesions in 204 sport and leisure horses (Sykes, 20196). However, recently was not as 
effective, with reported healing rates of 22% compared with the 73% of horses receiving 
misoprostol alone (Varley, Bowen, Nicholls, Habershon-Butcher, & Hallowell, 2016). 
Nevertheless, authors recommend sucralfate should only be used if omeprazole can be 
administered after 8 hours of feed deprivation, a minimum of 30 (preferably 60–90) minutes 
before feeding, ensuring that sucralfate is administered at least 30 minutes after omeprazole 
(Rendle et al., 2018).  
 
10.1.4. Synthetic prostaglandins 
The synthetic prostaglandin E2 analogue, misoprostol, has been recommended to treat EGUS 
(Buchanan & Andrews, 2003; Sykes, Hewetson, et al., 2015). In a more recent study, 
misoprostol (5 mg/kg, orally every 12 hours) was found to be superior to combined omeprazole 
(4 mg/kg, orally every 24 hours) and sucralfate (12 mg/kg, orally every 12 hours) therapy in 
horses with EGGD (Varley et al., 2016). Misoprostol may cause diarrhoea and/or colic signs, 
and it is not advised to be used in pregnant mares, because it might induce parturition and 
termination of the pregnancy (Camacho-Luna et al., 2018; Rendle et al., 2018). 
 
10.1.5. Antimicrobial agents 
As the role of bacteria in the pathogenesis of EGGD is still unclear, allied to the inexistence of 
evidence to support the use of antimicrobials in the horse (Sykes, Sykes, & Hallowell, 2014c), 
the committee declares that a routine use of antimicrobials in the treatment of EGGD is not 
acceptable until their efficacy is adequately recognised (Sykes, Hewetson, et al., 2015). 
  
10.2. Pharmacological prevention 
The pharmacological approach to prevention of ESGD is similar to treatment (Sykes, Hewetson, 
et al., 2015). Prevention should be applied according to each case, in which the greater the 
ability to reduce risk factors lesser will be the necessity for additional treatment.  Buffered and 
enteric-coated omeprazole formulations are usually used at 1.0 mg/kg PO SID (McClure, White, 
et al., 2005; White et al., 2007). However, there are no precise rules for their use regarding 
dosage and duration of therapy (Sykes, Hewetson, et al., 2015). 
 
6 Hepburn, R.J. & Proudman, C.J. (2014) Treatment of ulceration of the gastric glandular mucosa: Retrospective evaluation of 
omeprazole and sucralfate combination therapy in 204 sport and leisure horses [abstract]. In: Proc. 11th International Equine Colic 
Research Symposium. p 108 
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Recently, a meta-analysis run by Mason et al. (2019) led to evidence that omeprazole 
prophylaxis in active training horses reduces squamous gastric ulceration by 56.6% 
(n=556/1000) compared with no prophylaxis. 
Currently, there are no explicit instructions for the prevention of EGGD. It is still unclear of the 
prophylactic efficacy of omeprazole for EGGD, with reports of 23% of horses experiencing 
worsening of their EGGD grade in various recent studies (Sykes, Sykes, et al., 2014d, 2014a, 
2015), regardless of omeprazole treatment at doses at 1–4 mg/kg PO once daily. 
 
10.3. Environmental management of EGUS 
10.3.1. Modification of exercise intensity and duration  
In horses, intense exercise, racing, and race training have been shown to contribute to 
worsening of nonglandular gastric ulcers compared with horses kept at pasture or not in training, 
as discussed above (Dionne et al., 2003; Roy et al., 2005).  Also, endurance exercise has been 
shown to play a role in the cause of EGUS in horses, with reported prevalences of 67% of 
horses competing in 50- and 80-mile endurance rides (Nieto et al., 2004). Also, repeated oral 
administration of hypertonic electrolytes commonly used in these horses has been found to 
increase the gastric ulcer number and severity as well as hyperaemia of the gingival mucosa 
and hypersialia (Holbrook et al., 2005). However, despite additional work being required to 
evaluate electrolyte administration under different conditions adequately, these products are 
recommended to be used with caution in horses and should be best given after exercise, in 
hydrated animals and mixed in feed to minimise their effects on the squamous mucosa 
(Andrews et al., 2017). 
Regardless of the pathophysiological relationship, based on recent evidence provided by Sykes 
et al. (2019), it seems that restricting exercise to ≤4-5 days per week may reduce the risk of 
EGGD. Furthermore, training and exercise intensity should be reduced, when possible, until 
ulcers have healed (Sykes et al. 2019). 
 
10.3.2. Pasture turnout 
Stall-confinement generally has been associated with an increased risk of squamous ulcers, 
which therefore may not improve in stall-confined horses even when horses are fed grass hay 
ad libitum (Murray et al., 1996). Although pasture turnout may help control ESGD, the presence 
of certain other stress factors and whether the horse continues to be fed high NSC-containing 
feed may have a larger determining effect (Luthersson et al., 2009a; Malmkvist et al., 2012). 
However, pasture turnout is the preferred dietary method of prevention and controlling gastric 
ulcers.  
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10.4. Dietary management of EGUS  
Pasture grazing, high forage (DM intake, ≥1.5% bwt) and low concentrate (≤0.5% bwt) diets, a 
diet low in NSC, feeding smaller more frequent meals and providing ad libitum forages are the 
primary management practices that are suggested which may reduce the risk of squamous 
ulceration, as discussed in detail below (Andrews et al., 2017) 
 
10.4.1. Eliminate bolus feeding and increase forage intake 
The first and principal management practice that may help decrease squamous ulcers is to feed 
a forage-based diet ad libitum or guarantee that forage is provided every few hours and before 
exercise (in small amounts) (Reese & Andrews, 2009).  
Together with hay, horses which are stabled should be fed 3 or 4 smaller meals (without 
exceeding 0.5 kg/100 kg bwt every q.i.d. and containing 20% NSC or lower) per day (Nadeau et 
al. 2000). Smaller low NSC meals decrease intragastric fermentation, reduce the production of 
VFAs and improve gastric emptying rate (Nadeau et al., 2000).  
Providing alfalfa hay and good quality grass hay as the forage or feeding alfalfa hay along with 
concentrate significantly reduced the severity of gastric squamous mucosal ulceration in young 
horses in training, and may may be an effective way to ameliorate or prevent gastric ulceration in 
horses (Lybbert, Gibbs, Cohen, Scott, & Sigler, 2007; Murray & Eichorn, 1996; Nadeau et al., 
2000). Although absolute requirements have not been determined for horses, the total ration 
needs to be balanced to account for the alfalfa inclusion rate (Andrews et al., 2017). 
A recent study (Vondran et al. 2016) investigated the effects of feeding two alfalfa preparations 
with different particle sizes (alfalfa chaff vs alfalfa pellets) in comparison with grass hay on the 
gastric mucosa. However, no significant associations between lesion scores in both groups were 
found, and the study failed to improve gastric mucosal lesion scores in the alfalfa fed weanling 
horses (Vondran, Venner, & Vervuert, 2016).  
Straw as the only or main forage should be avoided as it was found to increase the risk of ESGD 
≥2 by at least 4.4 times (Luthersson et al., 2009a). 
The recommended levels of forage (grass and preserved forages) are preferably ≥1.5 kg 
DM/100 kg bwt for all horses, including those with high energy requirements (Andrews et al., 
20177). Lower levels may be required for those horses on a strict veterinary monitored weight 
loss programme (but never less than 1 kg DM/100 kg bwt) in which case appropriate measures 
need to be put into place to maximise the time spent chewing the restricted forage intake 
(Bruynsteen et al., 2014; Ellis et al., 2015). Additionally, a proper protein, vitamin and mineral 
 
7 Original reference: Harris, P.A., Coenen, M. and Geor RJ. 2013. Controversial areas in equine nutrition and feeding management: 
the editors’ views. R.J. Geor PAH and MC, editor. Waltham: Elsevier Health Sciences. 
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balancers will be essential in order to nutritionally balance the ration particularly if concentrate 
feeds are not required to be fed (Andrews et al., 2017). 
 
10.4.2. Decrease the size and increase the frequency of concentrate feeding 
Another recommendation is to feed smaller grain diets. Larger grain meals result in an increased 
gastric retention time, which increases the fermentation by resident bacteria, resulting in higher 
VFA production and a greater potential for squamous injury (Harris et al., 2006; Nadeau et al., 
2000).  The intake of NSC, and particularly grains, should, therefore, be restricted through the 
use of lower NSC complementary feeds. Based on previous studies, feeding a grain-based diet  
<0.5 kg grain/100 kg bwt (20%NSC) should help maintain stomach VFA concentration of acetic 
acid below 20 mmol/l and minimise the effect on squamous ulcers (Andrews, Buchanan, et al., 
2006). Feeding <2 g NSC/day or <1 g NSC/ meal has also been recommended (Luthersson et 
al., 2009a). This may be a difficult approach for some trainers of high intensity exercising horses 
to follow without a decrease in performance, hence the recurrence to the inclusion of various 
supplements as discussed below. 
 
10.4.3. Oils 
Additional energy could be provided through supplemental vegetable oil, which has been shown 
to decrease gastric acid output and increase prostaglandin E2 production at  0.3–0.5 ml/kg 
bwt/day (150–250 ml/day for a 500 kg horse), providing an effective and inexpensive way to 
increase the protective properties of the equine glandular gastric mucosa (Cargile, Burrow, Kim, 
Cohen, & Merritt, 2004). However, Frank, Andrews, Elliott, and Lew (2005) found that ESGD 
induced in horses with ulcerogenic diets (high grain ration) were not prevented by oil 
supplementation. Horses in that study did not have many glandular ulcers, so glandular ulcer 
healing rates could not be assessed. In contrast, in a recent study (Martínez, Zuluaga, & 
Silveira, 2016) where the objective was to resolve rather than to prevent the lesions, authors 
demonstrated positive therapeutic effects only in the glandular mucosa with corn oil 
supplementation. However, PGE2 concentration had little influence on the restitution of gastric 
epithelium. Therefore, additional studies should be conducted to elucidate some aspects related 
to the activation of antioxidant defence systems of the gastric mucosa resulting from other 
NSAIDs used in horses (Martínez et al., 2016) 
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10.4.4. Nutraceuticals, nutritional supplements and other alternatives 
The use of nutraceuticals and feed supplements has increased due to their ease of use and 
availability (Sykes, Hewetson, et al., 2015).  
Although pectin-lecithin complexes have been previously reported to increase the total mucus 
concentration in gastric fluid (Köller, Recknagel, Spallek, Breuer, & Schusser, 2010), other 
studies (Murray & Grady, 2002; Sanz, Viljoen, Saulez, Olorunju, & Andrews, 2014; Venner, 
Lauffs, & Deegen, 1999) failed to demonstrate a protective effect in fed/fasting models of ESGD. 
Authors also have found promising results in a combination of an antacid (magnesium 
hydroxide), a pectin-lecithin complex and Saccharomyces cerevisiae as a prophylactic agent 
against both ESGD and EGGD (Sykes, Sykes, & Hallowell, 2014e).  
Calcium carbonate has been shown to improve recovery of VFA-induced sodium transport in 
squamous mucosa in vitro Ussings chambers (Andrews, Buchanan, et al., 2006), which suggest 
that calcium carbonate preparations may have some efficacy in maintaining mucosal integrity, 
but because of the short duration effect on gastric fluid pH, more frequent feedings may be 
necessary to help prevent squamous ulcers. Woodward et al  (2014) evaluated the efficacy of 
two commercially available feed supplements, containing calcium bicarbonate, sodium 
bicarbonate, lecithin and pectin (Egusin 250® (E-250) and Egusin SLH® (E-SLH), Centaur 
Animal Health8), showed an improvement in the severity of gastric ulcers after a period of 35 
days of treatment. 
Similarly, a feed supplement containing salts of organic acids in combination with B-vitamins 
may be beneficial in the management of ESGD, and a preparation containing sea buckthorn 
berries was shown to have protective properties against the development of EGGD (Huff et al., 
2012). 
Kerbyson et al. (2016) developed a clinical trial which demonstrated that a nutraceutical 
supplement (Succeed®, Freedom Health LLC9) that provides several ingredients targeted to 
support gastrointestinal health is noninferior to omeprazole in terms of its ability to improve 
squamous ulceration in the horse when provided in the diet. When used at a dosage of 27g PO 
SID for at least 90 days, was found to be noninferior to 4 mg/kg omeprazole administered SID at 
the end of 90 days, using the complete resolution of ulceration as the measure of success. The 
healing rate on omeprazole compared with Succeed was higher at days 30 and 60. Then at day 
90, there was no difference between the two treatments reporting 52.6% of horses on 
omeprazole and 52.9% of horses on Succeed.  
 
8 Centaur Animal Health, 1351-F W. Highway 56 Olathe, KS 66061, USA. 
9 Freedom Health LLC, 65 Aurora Industrial Pkwy, Aurora, OH 44202, USA. 
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In a preliminary study (Craveiro, 2017), Trigonella foenum-graecum L. seed aqueous extract fed 
to horses was shown to be efficient in the treatment of EGGD (P = 0,018) in comparison to 
untreated control horses and found positive results in increasing gastric pH value. Still, positive 
treatment response of the ESGD lacked. 
Another recent report (Bush, van den Boom, & Franklin, 2018) focused on the potential of aloe 
vera as an alternative treatment, however, in the horse treatment response with aloe vera (17.6 
mg/kg bwt BID for 28 days) was inferior to treatment with omeprazole buffered paste at 4 mg/ kg 
bwt SID. 
Nonetheless, there is still little evidence to support the use of the unlicensed products for the 
treatment of EGGD, such as ranitidine, aloe vera, pectin/lecithin complexes, polysaccharides, 
kaolin, bismuth subsalicylate, sea buckthorn, acupuncture and homoeopathy (Rendle et al., 
2018). While some of these products/procedures may contribute for prevention purposes, the 
beneficial effects in treatment are dubious, and as interactions with other treatments are 
unknown, it is in the author's opinion that their use should be limited and entails further 
investigation (Rendle et al., 2018). 
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III. Retrospective study  
This study took place at the Equine Unit of the Teaching Hospital, FMV-ULisboa. The cases 
described below were evaluated between June 2010 and May 2015, during which time the 
author took her internship.  
 
1. Objectives 
• To determine the presence of EGUS in the horses referred for gastroenterology 
evaluation and measurement of gastric pH value; 
• To classify the gastric ulcer lesions observed according to the gastric ulcer scoring 
system established by MacAllister et al. (1997);  
• To identify the possible risk factors associated with the appearance of gastric lesions; 
• To evaluate the response to treatment with omeprazole of patients diagnosed with 
EGUS;  
• To determine associations between the severity of gastric ulceration and clinical 
symptoms; and between both level of implementation of recommended management 
changes and endoscopic screening interval, and the treatment outcome. 
 
2. Material and Methods 
2.1. Sample selection 
The initial inclusion criteria were that the horse had to be referred for EGUS suspicion, either 
from demonstrating vague clinical signs potentially attributable to gastrointestinal discomfort 
(behavioural, appetite and/or performance changes) or from displaying apparent clinical signs of 
abdominal pain.  
Furthermore, eligible horses had to meet two other inclusion criteria namely, to have grade 1 or 
greater gastric ulceration according to the McAllister et al. (1997) and to have had undergone at 
least two gastroscopic examinations, before and after treatment with omeprazole. 
The horses that underwent only one gastroscopic examination were excluded from the study 
group but were included to document the prevalence of gastric ulcer referrals. The remaining 
horses, our study population, underwent at least two examinations.  
Treatment with acid suppressive therapy was recommended for this selected group, as well as 
environmental and dietary changes.  
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2.2. Epidemiological questionnaire 
A questionnaire was filled in for all gastroscopies, before and after treatment with omeprazole. 
The purpose was to either evaluate the presence of any nonspecific signs of gastric ulcers, 
elaborate a complete clinical history or to evaluate any possible changes of clinical signs or 
behaviour following the treatment period. The questionnaire is available in Annexe 2. 
 
2.3. Physical examination 
Before the gastroscopic exam, each horse underwent a physical examination, which included 
measuring the horse’s weight, assessment of dehydration level by inspection of the mucous 
membranes (oral and ocular), capillary refill time, and skin pinch test on the neck, measurement 
of rectal temperature, evaluation of heart rate and respiratory rate, auscultation of the abdomen 
on both sides (colon and cecum motility), and finally inspection of the teeth, mane, coat, and 
hooves (Table 1). 
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Table 1 - Parameters included in the physical examination, reference range and grading system 
(Rose & Hodgson, 2000). 
Physical examination checklist Reference range and grading system  
Body Weight (Figure 4) Kg 
Colouration of mucous membranes 
(Figure 5) 
0 – pink (normal) 
1 - hyperaemic 
2 - icteric 
Capillary refill time  0 - < 2 seconds (normal) 
1 - > 2 seconds (increased) 
Skin pinch test (neck) 0 – Flattens in <2 seconds (normal) 
1 – Slightly elevated for 2-4 seconds (moderately 
dehydrated) 
2 – Remains raised >4 seconds (severely 
dehydrated)  
Rectal temperature  36,5-39ºC (normal)  
Heart rate 28-40 bpm (normal) 
Respiratory rate  8-16 mpm (normal) 
Auscultation of abdominal sounds 
Ileocecal valve sounds (right paralumbar 
fossa) 
Colon motility 
 
Every 30 seconds-1 minute 
 
Every 1-2 minutes 
Dental care 0 – up to date 
1 – in need (sharp edges) 
Mane and coat 0 – Shiny 
1 - Dull 
Hooves’ quality (Figure 6) 0 - Normal and hydrated 
1 - Dry 
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Figure 4 - Illustrative image of weighing (Original photographs). 
 
 
Legend: A - Weighing-machine; B - Weighing of the horse.  
 
Figure 5 - Oral mucosa classification (Original photographs). 
   
Legend: A - Normal pink color; B - Hyperaemic coloration; C - Icteric coloration. 
 
Figure 6 - Classification of the hooves’ quality (Original photographs). 
  
Legend: A - Normal and hydrated hoof; B - Dry and cracked hoof. 
A B 
A 
B 
A B C 
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2.4. Gastroscopy examination 
To examine the stomach for ulceration lesions, gastroscopy was performed on all horses. The 
horses endured a fasting period before examination. Feed was withheld for 12 hours (using a 
muzzle), and water for 2 hours.  
The horses were sedated with 0,1ml/100kg bwt of detomidine at 100mg/ml (Domosedan®, 
Esteve10) i.v. and 1,5ml/100kg bwt of butorphanol at 100mg/ml (Dolorex®, MSD Animal Health11) 
i.v. (Figure 7). 
The endoscopy was performed using a Storz® (Karl Storz12) equine video-gastroscope (Figure 
8), with a working length of 325 cm and with an outer diameter of 13 mm.  
The endoscope entered the horse’s nares, and once at the glottis, water was squirted through 
the endoscope air-water channel onto the rima glottis to induce a swallowing reaction and 
facilitate the progression of the endoscope into the oesophagus. Forcing the endoscope into the 
oesophagus may accidentally retroflex and then advance towards the mouth. The oesophagus 
was carefully examined while the endoscope advanced slowly, by insufflating air with the 
insufflation/irrigation valve.  
To observe the stomach thoroughly, it was distended by insufflating air through the suction and 
irrigation system (Duomat®, Karl Storz13) until the non-glandular and glandular regions of the 
gastric surface could be observed. Whenever necessary, the gastric contents were removed by 
rinsing the stomach’s surface with tap water flushed through the biopsy channel, using a 100 ml 
syringe. In cases where there was excessive fluid within the stomach, it was aspirated, using the 
Duomat® pump system, referred above. 
During the examination, different structures were observed, namely the non-glandular and 
glandular surface, the margo plicatus, and the antrum and pylorus, excluding the portion that is 
covered by liquid gastric content, which is not completely eliminated by fasting and/or pump 
aspiration. In most cases, it was possible to advance the endoscope to see the major duodenal 
papilla. Once the procedure was completed, the air was removed from the stomach before 
withdrawing the endoscope. The oesophagus was better evaluated while the endoscope was 
being removed. 
Gastroscopic ulcer grading was carried out in real time. Besides, images of the oesophagus, 
fundus, margo plicatus, greater curvature and lesser curvature were saved from all horses for 
future analysis. 
 
10 Esteve veterinaria Laboratorios Dr. Esteve S.A., Av. Mare de Déu de Montserrat 221 08041 Barcelona (España). 
11 MSD Animal Health Lda., Edifício Vasco da Gama, nº 19, Quinta da Fonte, Porto Salvo 2770-192 Paço de Arcos. 
12 Karl Storz GmbH&Co. KG, Postfach 230, D-78503 Tuttlingen, Germany. 
13 Karl Storz GmbH&Co. KG, Postfach 230, D-78503 Tuttlingen, Germany.  
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Figure 7 - Sedation protocol (Original 
photographs). 
 
Legend: A - Detomidine (Domosedan®) and 
butorfanol (Dolorex®); B – 21-gauge needle 
and 2 ml syringe. 
    Figure 8 - Image of the Storz® equine-
gastroscope used for this study (Original 
photographs). 
 
 
Figure 9 - Gastroscopy procedure (Original 
photographs). 
 
   Figure 10 - Illustrative image of the 
horse immobilised for the gastroscopy 
procedure (Original photographs). 
 
 
A 
B 
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2.5. Gastric ulcer lesions scoring system 
The gastric mucosa was examined, and the gastric ulcer lesions observed were scored 
according to the gastric ulcer scoring system established by MacAllister et al. (1997). This being 
a retrospective study, the classification of gastric ulcers according to MacAllister was 
maintained, in order to equally classify the endoscopies carried out before and after the EGUS 
consensus classification. The grading system scores both types of mucosa together, according 
to the number of lesions and severity (Table 2). In this study, hyperkeratosis in the nonglandular 
part of the stomach was not registered as ulcers, since the MacAllister scoring system does not 
include hyperkeratosis as a lesion. In other studies and scoring systems (Andrews et al., 2002; 
Andrews & Nadeau, 1999), hyperkeratosis is included in grade 1 of EGUS. 
The type of mucosa affected was noted, and the approximate locations of the lesions were 
identified using a schematic representation (oesophagus, glandular mucosa, non-glandular 
mucosa, margo plicatus, pylorus), in order to compare with follow-up exams. The gastroscopy 
report form is available in Annexe 3 for further observation. 
 
Table 2 – Number/Severity scoring system for grading of EGUS lesions in horses (Adapted by 
MacAllister et al. (1997)). 
Score Number Severity 
0 No lesions  No lesions 
1 1 to 2 lesions  Appears superficial (only mucosa missing) 
2 3 to 5 lesions  Deeper structures involved (greater depth than 1) 
3 6 to 10 lesions  Multiples lesions and variable severity (1,2 and/or 4) 
4 > 10 lesions or diffuse (or 
very large) lesions 
Same as 2 and has active appearance 
(active=hyperaemic and/or darkened lesion crater) 
5 n/a Same as 4 plus active haemorrhage or adherent blood 
clot 
 Legend: n/a = Not applicable. 
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Figure 11 - Exemplification of characteristic lesions of each severity score according to the 
adapted scoring system of MacAllister et al. (1997) (Original photographs). 
  
  
  
Legend: A – Grade 0; B- grade 1; C- grade 2; D – grade 3; E- grade 4; F – grade 5. 
 
 
A B 
C D 
F 
E 
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2.6. Measurement of gastric pH value 
Measurement of gastric pH required the collection of gastric fluid (Figure 12). Before insufflating 
the stomach, a tube was placed through the endoscope’s biopsy channel, using a three-way 
stopcock and a 100ml syringe (B Braun14). The gastric pH level was measured using colorimetric 
pH indicator strips ranging between 0 and 6 (Acilit®, Merck15).  
 
Figure 12 - Collection of gastric fluid and measurement of gastric pH value (original 
photographs). 
  
Legend: A –100ml syringe and gastric fluid harvesting probe; B - colourimetric pH indicator strips (Acilit®). 
 
2.7. Questionnaire on treatment follow up 
After the recommendation of treatment, as well as environmental and dietary changes, a 
questionnaire was performed to confirm which treatment each horse endured, for how long, and 
which changes were established (available in Annexe 4). 
 
2.8. Statistical analysis 
Results were recorded in a Microsoft Excel 2016® spread sheet and statistically analysed using 
SPSS statistical software program, version 22.0 (SPSS Statistics Base 22.0). 
To characterize the sample and results, descriptive statistic was preformed and analysed. 
Parametric T tests for paired samples were performed regarding all the quantitative variables to 
assess differences between means at the two moments. Normality distributions and 
homogeneity of variances were ensured through Shapiro-Wilk and Levene tests, respectively. 
 
14 B Braun Medical Lda., Estrada Consiglieri Pedroso, 80, Portugal. 
15 Merck S.A., Rua Alfredo da Silva, 3C, 1300-040 Lisboa, Portugal. 
A B 
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To compare paired results in a dicotomical nominal scale (yes/no) McNemar's nonparametric 
test was used. To compare dependent variables in an ordinal scale (ulcer lesion scores) 
between two groups the non-parametric Mann–Whitney U test was performed, while for 
comparisons between three or more sets of values a non-parametric Kruskal-Wallis test was 
used. Wilcoxon paired tests were used regarding the ordinal qualitative variables (ulcer scores) 
to compare ulcer scores on two distinct moments as to assess treatment outcome. Chi-squared 
tests (χ2) were used to evaluate the relation between two categorical/qualitative variables. Chi-
square independent test was used to evaluate associations between the lesion score evolution 
(no change, decrease, increase) and the endoscopic screening interval. When the conditions of 
application of the chi-square were not verified, the Monte Carlo simulation was used, and trends 
were identified for adjusted residuals ≥2. Chi-square homogeneity test was used to determine 
whether the distribution of proportions in numeric score evolution and in Severity score evolution 
are homogeneous according to the different levels of implementation of the corrective measures. 
Significance was determined when p-value <0.05. 
 
3. Results 
3.1. Sample selection 
The initial group referred for EGUS suspicion totalled sixty-nine horses (n=69), aged 2-22 years, 
of different genders (mares, geldings and stallions), all of which presented a certain degree of 
gastric lesion (grade ≥1). The horses that underwent only one gastroscopic examination were 
excluded from the study group but were included to document the prevalence of gastric ulcer 
referrals (n=33/69, 48%). The remaining horses, our study population (n=36/69, 52%), 
underwent at least two examinations. Figure 13 shows the number of examinations per horse. 
 
Figure 13 - Number of gastroscopies performed on each horse (n=69). 
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Treatment with acid suppressive therapy was recommended for this selected group (n=36/69), 
as well as environmental and dietary changes. The final sample population were the horses 
treated with an enteric coated omeprazole paste formulation (n=22/36), 4mg/kg bwt, SID, per os, 
for 28 days, followed by 2mg/kg bwt, SID, per os, for another 28 days. Horses who were treated 
with other pharmacologic agents (GNF) (n=1/36), as well as those who exclusively underwent 
environmental and dietary changes (n=2/36), and others because of incomplete history 
information (n=11/36) were excluded from our sample population. 
 
3.2. Epidemiological questionnaire 
3.2.1. Sample characterization 
First examination horses were aged between 2 and 22 years, and the average age was 9,86 
(SD=4,246).  
Detailed characterization of the sample population according to the age, gender, equestrian 
discipline, training regime, temperament and number of riders and grooms is presented in Table 
3. The horses were arranged in four age categories. Overall 59,10% (13/22) were aged between 
6 and 10 years and the majority were male 86,4% (19/22). The main equestrian disciplines are 
referred, being the most frequent show-jumping, representing 45,5% (10/22), while the training 
regime most described was a high intensity training regime in 68,9% of cases (15/22). 
Regarding the horse’s temperament, 72,7% (16/22) where described as being calm and docile, 
and the remaining 27,3% (6/22) as being aggressive and/or nervous. The majority were ridden 
by one rider (59,10%, 13/22) and were handled by one groom (63,6%, 14/22). 
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Table 3 - Distribution regarding sample characterization according to age, gender, equestrian 
discipline, training regime, temperament, also number of riders and grooms (n=22). 
Sample characterization 
 
Absolute 
Frequency 
Relative 
Frequency (%) 
Cumulative 
Frequency (%) 
Age Less than 5 years 1 4,5 4,5 
6-10 years 13 59,1 63,6 
11-15 years 6 27,3 90,9 
More than 16 years 2 9,1 100,0 
Gender Stallion 9 40,9 40,9 
Gelding 10 45,5 86,4 
Mare 3 13,6 100,0 
Discipline Hacking 3 13,6 13,6 
Show-jumping 10 45,5 59,1 
Dressage 5 22,7 81,8 
Endurance 3 13,6 95,4 
Bullfighting 1 4,5 100 
Training regime Absent 2 9,1 9,1 
Low intensity (≤ 3x a 
week) 
5 22,7 31,8 
High intensity (4-6x a 
week) 
15 68,2 100,0 
Temperament Docile/calm 16 72,7 72,7 
Nervous/aggressive 6 27,3 100,0 
Number of 
riders 
One 13 59,1 59,1 
More than one 9 40,9 100,0 
Number of 
grooms 
One 14 63,6 63,6 
More than one 8 36,4 100,0 
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3.2.2. Clinical complaints 
On the first examination, 59,1% (n=13/22) of horses were referred for gastroenterologic 
examination for having displayed colic episodes in the last year, while at the follow-up 
examination, this complaint decreased by 9,1% (n=2/22). The colic episodes were described 
according to the duration and pain scale, and the distribution of such results are present in Table 
4.  
 
Table 4 - Distribution of presence of colic in the last year and characterisation of the colic 
episodes. 
 
First exam Second exam 
Presence of colic in the last year (n=22)   
No 9 (40,9) 11 (50,0) 
Yes 13 (59,1) 11 (50,0) 
Duration of colic episode   
Half a day 10 (76,9) 9 (81,8) 
1 day 3 (23,1) 2 (18,2) 
Pain scale   
Very mild 1 (7,7) 0 (0) 
Mild 1 (7,7) 3 (27,3) 
Moderate 8 (61,5) 5 (45,5) 
Severe 1 (7,7) 3 (27,3) 
Very severe 2 (15,4) 0 (0) 
Legend: Values are expressed as the number (percentage). 
 
Table 5 shows the descriptive statistics regarding the number of colic episodes accounted, 
before and after treatment. 
On the first examination, the group who displayed colic in the last year experienced between one 
and six episodes (minimum, maximum), 38,5% (n=5/13) having experienced one colic episode. 
At the second examination, the number of colic episodes described in the last year decreased in 
the cases which reported between one and three episodes, while 18,2% (n=2/11) were stated to 
have had ten episodes, representing an increase compared to the first questionnaire. 
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Table 5 - Minimum, maximum, mean, median and standard deviation regarding the number of 
colic episodes accounted in the last year, determined for both moments. 
 Number of colic episodes 
 
First exam (n=13) Second exam (n=11) 
Mean 2,62 3,91 
Median 3 3 
SD 1,66 3,239 
Minimum 1 1 
Maximum 6 10 
 
Table 6 - Distribution of number of colic episodes accounted in the last year at both examination 
moments (n=13). 
Number of colic episodes 
in the last year 
First 
exam 
Second 
exam 
Observations 
0 
 
0 (0) 2 (15,4)  
1 
 
5 (38,5) 3 (23,1) 1 total remission 
1 increased (4 episodes) 
2 
 
1 (7,7) 1 (7,7) 1 = 
3 
 
4 (30,8) 2 (15,4) 1 total remission; 
 2 increased (4; 10 episodes); 1 = 
4 
 
1 (7,7) 3 (23,1) 1 = 
5 
 
1 (7,7) 0 (0) 1 decreased (3 episodes) 
6 
 
1 (7,7) 0 (0) 1 increased (10 episodes) 
10 
 
0 (0) 2 (15,4)  
Legend: Values are expressed as the number (percentage); (=) accounted the same number of episodes. 
 
No differences were significant when comparing the information gathered in both questionnaires 
regarding the colic episodes (p>0.05).  
Concerning the presence of behavioural and physical changes referred by the horse’s owners, 
riders or grooms, Table 7 indicates the distribution of such changes in both moments.   
Although differences in several variables were described between the two examinations, there 
were only statistically significant differences in weight loss (Mc Nemar; p=0,008) and occasional 
signs of mild colic (Mc Nemar; p=0,031). 
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Table 7 - Comparison between results of the epidemiological questionnaires (n=22). 
Clinical complaint First exam Second exam Observations 
Nervous temperament 6 (27,3) 6 (27,3) = 
Signs of mild colic once in a while 7 (31,8) 1 (4,5) 6 improved 
Plays with water 3 (13,6) 6 (27,3) 3 more recorded 
Lays snout in drinking bowl 1 (4,5) 1 (4,5) = 
Crib-biting 3 (13,6) 2 (9,1) 1 improved 
Grinds teeth when stabled 0 (0) 0 (0) NTA 
Grinds teeth during training 3 (13,6) 6 (27,3) 3 more recorded  
Takes time to eat 5 (22,7) 2 (9,1) 3 improved 
Eats partially once feed is given 2 (9,1) 3 (13,6) 1 more recorded  
Turns rear when entering stall 4 (18,2) 3 (13,6) 1 improved 
Stays still 7 (31,8) 6 (27,3) 1 improved 
Approaches person 15 (68,2) 16 (72,7) 1 improved 
Sad 5 (22,7) 1 (4,5) 4 improved 
Lack of energy during training 10 (45,5) 5 (22,7) 5 improved 
Lacks concentration during training 7 (31,8) 7 (31,8) = 
Unlearning 0 (0) 0 (0) NTA 
Weight loss 12 (54,5) 4 (18,2) 8 improved 
Signs of abdominal discomfort 8 (36,4) 6 (27,3) 2 improved 
Dull coat 6 (27,3) 3 (13,6) 3 improved 
Legend: Values are expressed as the number (percentage). (=) clinical complaint reported in the same 
number of horses. 
 
3.3. Physical examination 
The measured temperatures were within the reference values and were between 37,5ºC and 
38,5ºC. The descriptive statistics and distributions regarding first and second physical 
examination results relative to body weight, respiratory and heart rate are present in Table 8. 
At follow-up examination, the average weight increased by 10 kg to 495,23 kg (SD=62,27) 
associated with an increase of the maximum weight to 600kg, and of the median to 479,50 kg. In 
general, after treatment, 50% (11/22) of cases increased their body weight, while 9,1% (2/22) 
decreased, and 40,9% (9/22) maintained their weight.  
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Table 8 - Descriptive statistics regarding weight, respiratory and heart rates (n=22). 
 
 
Body weight (Kg) Respiratory rate 
(N=8-16 mpm) 
Heart rate 
(N=28-40 bpm) 
First exam Second exam First exam Second exam First exam Second exam 
Mean 485,27 495,23 13,68 15,86 36,45 36,95 
Median 460,50 479,50 12 16 36 36 
SD 64,76 62,27 5,64 6,36 9,56 6,49 
Minimum 387 386 8 8 24 24 
Maximum 590 600 24 34 54 49 
 
Most of the study group, namely 72,7% (n=16/22) of the horses, at first examination registered 
respiratory rates in the normal reference range (8-16 mpm), whereas only 27,30% (n=6/22) had 
abnormal increased respiratory rates. At second examination, there was a general increase in 
the respiratory rates, reaching a maximum of 34 bpm and 45,5% (10/22) presented abnormally 
increased respiratory rates. 
Concerning the heart rate, they were slightly lower at the second examination, where the 
maximum value was 49 bpm, although neither the average (36,95 bpm (SD=6,49)) nor the 
median (36 bpm) change significantly. Also, from the group of horses that presented increased 
heart rate initially only one presented a lower heart rate reaching the normal reference range in 
the second examination, and the remaining 22,7% (5/22) of the cases showed increased heart 
rates. 
The distribution of the remaining physical examination data from both moments is presented in 
Table 9.  
Concerning the other physical examination findings in both examinations, it is worth mentioning 
that the weight (Paired T test: t(21) = -2,784; p=0,011) showed significant differences (p<0.05). No 
other significant differences were found. 
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Table 9 - Distribution of qualitative analysis for physical examination findings in both 
examinations (n=22). 
Physical examination findings Classification First exam Second exam 
CRT < 2 seconds 20 (90,9) 22 (100) 
> 2 seconds 2 (9,1) 0 (0) 
Mucous membranes Pink 13 (59,1) 16 (72,7) 
Hyperaemic 4 (18,2) 4 (18,2) 
Icteric 5 (22,7) 2 (9,1) 
Skin pinch test Flattens in < 2” 13 (59,1) 15 (68,2) 
Slightly elevated for 2”-4” 8 (36,4) 7 (31,8) 
Remains raised for > 4” 1 (4,5) 0 (0) 
Cecum motility Normal (30''-1') 14 (63,6) 19 (86,4) 
Decreased 8 (36,4) 3 (13,6) 
Colon Motility Normal (1-2 min.) 15 (68,2) 16 (72,7) 
Decreased 7 (31,8) 6 (27,3) 
Dental care Up to date 17 (77,3) 16 (72,7) 
In need (sharp edges) 5 (22,7) 6 (27,3) 
Mane and Coat Shiny 12 (54,5) 11 (50) 
Dull 10 (45,5) 11 (50) 
Hooves Normal and hydrated 16 (72,7) 18 (81,8) 
Dry 6 (27,2) 4 (18,2) 
Legend: Values are expressed as the number (percentage). 
 
3.4. Gastroscopy examination 
An in-depth examination of the non-glandular mucosa was possible in all horses. In the majority, 
a thorough examination of the glandular region was also possible, except for a small area where 
residual fluid was merging at the ventral part of the fundus.  
Of the 22 horses examined, 100% presented a certain degree of gastric lesion, from hyperaemia 
and ulceration of the mucosa observed. The first gastroscopy showed that 9,1% (2/22) had only 
lesions in the glandular part of the stomach; 31,8% (7/22) only in the nonglandular part and 
59,10% (13/22) in both parts of the stomach.  
After the treatment period with omeprazole, the control gastroscopy was performed, and it was 
found that several of the horses had some degree of healing (involution) of the lesions initially 
observed, with two cases of total remission. The distribution regarding the lesion location is 
shown in Table 10.  
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Gastric parasites were found in one horse at both examinations (Figure 14). 
Table 10 - Distribution regarding lesion location (n=22). 
Legend: Values are expressed as the number (percentage).  
 
Figure 14 - Image of the gastric mucosa of a parasitised horse (original photographs). 
  
Legend: A and B - Parasites of the genus Gastrophilus in the glandular and non-glandular squamous 
mucosa. 
 
The distribution regarding the lesion scores registered in both examinations is displayed in Table 
11.  Among the study group, the most prevalent lesion number score was grade 4, 59,1% 
(13/22) of horses on the first examination and 36,4% (8/22) on the second examination. In terms 
of the lesion severity score, the most prevalent were grades 3, 4 and 5, each being present in 
22,7% (5/22) of horses on first examination and all showing a decrease on the second 
examination. 
 
Lesion location First exam Second exam 
Oesophagus 0 (0,0) 2 (9,1) 
Non-glandular squamous mucosa 20 (90,9) 17 (77,3) 
Margo plicatus 7 (31,8) 4 (18,2) 
Glandular mucosa 15 (68,2) 14 (63,6) 
Pylorus 8 (36,4) 9 (40,9) 
A B 
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Table 11 - Distribution regarding gastric lesion scores at both gastroscopic examinations (n=22). 
Score Number Severity 
 First exam Second exam First exam Second exam 
0 0 (0,0) 2 (9,1) 0 (0,0) 2 (9,1) 
1 1 (4,5) 2 (9,1) 3 (13,6) 4 (18,2) 
2 4 (18,2) 5 (22,7) 4 (18,2) 6 (27,3) 
3 4 (18,2) 5 (22,7) 5 (22,7) 2 (9,1) 
4 13 (59,1) 8 (36,4) 5 (22,7) 4 (18,2) 
5 n/a n/a 5 (22,7) 4 (18,2) 
Legend: Values are expressed as the number (percentage); n/a= Not applicable.  
 
Below are two tables (Tables 12 and 13) that summarize the results attained in the gastroscopy 
of both protocol phases, and the rightmost column indicates the evolution of the horses after 
therapy with enteric coated omeprazole paste, at the treatment dose of 4mg/kg PV PO for 28 
days, followed by maintenance dose 2 mg/kg PV for 28 days. 
Table 12 - Number of horses per numeric score in each gastroscopy (n=22). 
Number score First exam Second exam Observations 
0 0 2 NTA 
1 1 2 1→ grade 3 
2 4 5 2 → no evolution 
1 →grade 3 
1→grade 4 
3 4 5 1→grade 2 
1→grade 1 
1→ total remission 
4 13 8 3→grade 3 
2→grade 2 
1→grade 1 
1→ total remission 
 
58 
 
Table 13 - Number of horses per severity score in each gastroscopy (n=22). 
Severity score First exam Second exam Observations 
0 0 2 NTA 
1 3 4 1→ no evolution 
1→grade 3 
1→ total remission 
2 4 6 2→ no evolution 
1→ grade 1 
1→ grade 4 
3 5 2 1→ no evolution 
1→ grade 1 
2→ grade 2 
1→ grade 4 
4 5 4 1→ no evolution 
1→ grade 1 
2→ grade 2 
1→ grade 5 
5 5 4 3→ no evolution 
1→ grade 4 
1→ total remission 
 
 
While 36,36% (8/22) of the cases maintained the initial ulcer scores, it should be referred that 
45,45% (10/22) decreased, and the remaining 18.18% (4/22) increased.  
Although there were confirmed changes in the scores after treatment, Table 14 shows that there 
were no significant differences of the lesion number score (Wilcoxon=-1,751; p=0,080), and the 
lesion severity score (Wilcoxon=-1,568; p=0,117), therefore no significant treatment effect. 
 
3.4.1. Measurement of gastric pH value 
The pH values recorded were between 1.5 and 6 (Table 15). It should be referred that the cases 
with no record of gastric pH, one at first examination and five at the second examination, were 
due to the presence of ingesta. 
Comparing the pH values recorded in both exams, there were 31.83% (7/22) of cases with pH 
increase, with 27.27% (6/22) showing pH values above 4, and only 4.55% (1/22) maintained a 
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value below 4, while 18.18% (4/22) of cases registered a decrease in pH maintaining values 
below 4, and finally 27.27% (6/22) of cases had no changes in pH values remaining above 4. 
No significant differences were found in pH values between both examinations (p>0.05). 
 
Table 14 - Testing of changes in the number and the severity of lesions before and after 
treatment. 
 N 
Mean 
Rank 
Sum of 
Ranks 
Wilcoxon p 
Lesion Number 
Score - 2nd exam 
vs 1st exam 
Negative Ranks 10a 8,00 80,00 -1,751 0,080 
Positive Ranks 4b 6,25 25,00   
Ties 8c     
Total 22     
Lesion Severity 
Score - 2nd exam 
vs 1st exam 
Negative Ranks 10d 7,70 77,00 -1,568 0,117 
Positive Ranks 4e 7,00 28,00   
Ties 8f     
Total 22     
Legend: a - Lesion Number Score at 2nd exam < Lesion Number Score at 1st exam; b - Lesion Number 
Score at 2nd exam > Lesion Number Score at 1st exam; c - Lesion Number Score at 2nd exam = Lesion 
Number Score at 1st exam; d - Lesion Severity Score (2nd exam) < Lesion Severity Score (1st exam); 
e - Lesion Severity Score (2nd exam) > Lesion Severity Score (1st exam); f - Lesion Severity Score (2nd 
exam) = Lesion Severity Score (1st exam). 
 
Table 15 - Descriptive statistics regarding the gastric pH value (n=22). 
 
Descriptive statistics 
 
First exam Second exam 
n Valid 21 17 
 
Missing 1  5 
Mean 
 
3,98 4,77 
Median 
 
5 5,5 
SD 
 
2,01 1,37 
Minimum 
 
1,5 2 
Maximum 
 
6 6 
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3.5. Identification of associations between independent variables and ulcer scores. 
The presence of colic in the last year (p=0,029) was significantly associated with lesion number 
scores (Table 16). The horses that presented colic in the last year displayed a higher mean rank 
lesion number score (MR=13.73) in comparison with the horses that did not present colic 
(MR=8.28) whereas the coat condition (p=0,038) was significantly associated with lesion 
severity. The horses with shinny coats have a higher mean rank lesion number score 
(MR=13.22) in comparison with the horses with dull coats (MR=6,92).  
There were no significant associations (p>0.05) observed between the remaining clinical signs 
and ulcer scores, nor between any of the risk factors evaluated and the ulcer scores. 
Furthermore, there was no significant association between the location of lesions or pH value 
and ulcer scores. 
 
Table 16 – Comparison of lesion number score and lesion severity score with independent 
variables (P-values resulting from non-parametric tests of Mann-Whitney and Kruskal-Wallis). 
 DV (first exam) 
IV (first exam) Lesion Number Score Lesion Severity Score 
 p p 
Gender a 0,187 0,420 
Agea 0,179 0,147 
Temperamentb 0,453 0,598 
Training regimea 0,465 0,728 
Disciplinea 0,139 0,407 
Number of Ridersb 0,521 0,246 
Number of Groomsb 0,616 0,163 
Colic in the last yearb 
Mean Rank 
0,029* 
No=8.28 Yes=13.73 
0,172 
Pain scalea 0,244 0,444 
Signs of mild colic once in a whileb 0,067 0,388 
Plays with water b 0,144 0,130 
Lays snout in drinking bowlb 0,476 0,171 
Crib bittingb 0,589 0,282 
Grinds teeth when stabled c c 
Legend: IV – Independent variables; DV – Dependent variables; c - Test wasn’t performed due to existing 
only one condition in Independent variable; (*) Significative for α=0,05; (a) Kruskal-Wallis Test; (b) Mann-
Whitney Test. 
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Table 16 – (Continuation) 
Grinds teeth during trainingb 0,144 0,494 
Takes time to eatb 0,825 0,631 
Eats everything once feed is givenb 0,423 0,537 
Eats partially once feed is givenb 0,245 0,771 
Turns rear when entering stallb 0,083 0,207 
Stays stillb 0,873 0,313 
Approaches personb 0,873 0,313 
Sadb 0,894 0,779 
Lack of energy during trainingb 0,794 0,225 
Lacks concentration during trainingb 0,130 0,885 
Unlearningb c c 
Weight lossb 0,233 0,281 
Signs of abdominal discomfortb 0,143 0,163 
Dull coat b 
Mean Rank 
0,588 0,038 
No=13,22; Yes=6,92 
Respiratory Rateb 0,279 0,940 
Heart Ratea 0,279 0,407 
CRTb 0,949 0,815 
Mucous membranesa 0,957 0,906 
Skin pinch testa 0,719 0,653 
Cecum motilityb 0,396 0,464 
Colon motilityb 0,605 0,614 
Dental careb 0,894 0,447 
Mane and Coatb 0,823 0,788 
Hoovesa 0,490 0,521 
Gastric parasites (gastrophilus)b 0,423 0,573 
Non-glandular squamous mucosa b 0,701 0,779 
Glandular mucosa b 0,078 0,407 
Margo plicatus b 0,891 0,891 
Pylorus b 0,110 0,095 
pH b 0,654 1,000 
Legend: IV – Independent variables; DV – Dependent variables; c - Test wasn’t performed due to existing 
only one condition in Independent variable; (*) Significative for α=0,05; (a) Kruskal-Wallis Test; (b) Mann-
Whitney Test. 
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3.6. Effect of screening interval on treatment outcome 
The second examination occurred between 63 and 208 days (Table 17). In most situations 
(86.4%), the second examinations occurred between one and four months after the first 
examination, as shown in Table 18. Distributions regarding EGUS score changes and 
endoscopic screening interval are displayed in Table 19. 
 
Table 17 - Descriptive statistics 
regarding the number of days 
between examinations. 
 
Descriptive statistics  
Mean 98,45 
Median 89,00 
SD 35,68 
Minimum 63 
Maximum 208 
   Table 18 - Distribution regarding endoscopic 
screening interval. 
 
Endoscopic screening 
interval 
Number of 
horses 
1-4 months 19 (86,4%) 
4-6 months 2 (9,1%) 
6 months - 1 year 1 (4,5%) 
Total 22 (100%) 
 
Table 19 - Distributions regarding score evolutions and endoscopic screening interval. 
EGUS score evolution after 
treatment 
Endoscopic screening interval 
1-4 months 4-6 
months 
6 months-1 
year 
Total 
Numeric score 
evolution 
No change 8 (36,36) 0 (0) 0 (0) 8 (36,36) 
Decreased 9 (40,91) 0 (0) 1 (4,55) 10 (45,45) 
Increased 2 (9,09) 2 (9,09) 0 (0) 4 (18,18) 
Total 19 (86,36) 2 (9,09) 1 (4,55 22 (100) 
Severity score 
evolution 
No change 7 (31,82) 1 (4,55) 0 (0) 8 (36,36) 
Decreased 9 (40,91) 0 (0) 1 (4,55) 10 (45,45) 
Increased 3 (13,64) 1 (4,55) 0 (0) 4 (18,18) 
Total 19 (86,36) 2 (9,09) 1 (4,55) 22 (100) 
Legend: Values are expressed as the number (percentage). 
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There was a significant association between the endoscopic screening interval and the numeric 
score evolution (2(4) =11,000; p=0,024) as displayed in Table 20. Adjusted residual values 
indicate a tendency for the endoscopic screening interval between 4-6 months to present an 
increase in numeric scores (resAjust=3,1).  
 
Table 20 - Chi- square tests to determine association between endoscopic interval and score 
evolution (n=22). 
 2  df Monte Carlo Sig.  
(2-sided) 
p 
Endoscopic screening interval x Numeric score evolution 11,000 a 4 0,024 
Endoscopic screening interval x Severity score evolution 3,401a 4 0,643 
a- The Monte Carlo variant was used due to non-satisfaction of the chi-square application conditions. 
 
3.7. Influence of implementation of recommended management changes over the 
treatment outcome 
According to the results gathered from the final questionnaire on treatment follow-up, Graphs 1 
and 2 reveal the distributions concerning the environmental and dietary changes that were 
implemented. The management changes worth mentioning are mainly dietary changes due to 
the high accession in the study group. The most accepted dietary changes were the addition of 
oils, decreased the size and increased the frequency of concentrate feeding in 81,8% (18/22) of 
cases and the increase of forage and fibre together with the implementation of continuous 
feeding in 90,91% (20/22) of cases. 
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Graphic 1 - Distribution regarding the level of implementation of environmental management 
changes (n=22). 
Graphic 2 - Distribution regarding the level of implementation of dietary management changes 
(n=22). 
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Overall, the management changes were in most cases only partially implemented, as shown in 
Graphic 3. 
 
Graphic 3 - Level of implementation of recommended management changes established 
(n=22).
 
To assess a possible influence of management changes over score evolution, the distributions 
of the levels of implementation of the recommended management changes according to score 
evolution are displayed in Table 21. 
It was determined that in any type of implementation (not implemented, partial or total 
implementation) (Table 22), there were no significant differences in numeric score evolution and 
severity score evolution (p>0,05). 
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Table 21 – Distributions of the levels of implementation of the recommended management 
changes according to score evolution. 
Level of implementation 
 
Numeric score 
evolution Total 
Severity score 
evolution Total 
NC DC INC NC DC INC 
Environmental 
Changes 
Nothing 4 
(57,1) 
1 
(14,3) 
2 
(28,6) 
7 
(100) 
3 
(42,9) 
2 
(28,6) 
2 
(28,6) 
7 
(100) 
Partial 3 
(21,4) 
9 
(64,3) 
2 
(14,3) 
14 
(100) 
4 
(28,6) 
8 
(57,1) 
2 
(14,3) 
14 
100,0 
Total 
implementation 
1 
(100) 
0 
(0) 
0 
(0) 
1 
(100) 
1 
(100) 
0 
(0) 
0 
(0) 
1 
(100) 
Total 
8 
(36,4) 
10 
(45,5) 
4 
(18,2) 
22 
(100) 
8 
36,4 
10 
45,5 
4 
18,2 
22 
100 
Dietary 
Changes 
Nothing 0 
(0) 
1 
(100) 
0 
(0) 
1 
(100) 
0 
(0) 
1 
(100) 
0 
(0) 
1 
(100) 
Partial 4 
(33,3) 
5 
(41,7) 
3 
(25,0) 
12 
(100) 
3 
(25,0) 
7 
(58,3) 
2 
(16,7) 
12 
(100) 
Total 
implementation 
4 
(44,4) 
4 
(44,4) 
1 
(11,1) 
9 
(100) 
5 
(55,6) 
2 
(22,2) 
2 
(22,2) 
9 
(100) 
Total 
8 
(36,4) 
10 
(45,5) 
4 
(18,2) 
22 
(100) 
8 
(36,4) 
10 
(45,5) 
4 
(18,2) 
22 
(100) 
Legend: NC – No score change; DC – Decrease in score; INC – Increase in score. Values are expressed 
as the number (percentage). 
 
Table 22 - Chi-square tests to determine association between level of implementation of 
recommended changes and score evolution. 
Independent variables  Dependent variables 2 p 
Implementation of environmental changes by Numeric score evolution 6,561a 0,150 
by Severity score evolution 3,457a 0,576 
Implementation of dietary changes by Numeric score evolution 1,986a 0,829 
by Severity score evolution 4,140a 0,463 
Legend: (a) - The Monte Carlo variant was used due to non-satisfaction of the chi-square application 
conditions. 
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4. Discussion 
In the present study, it was determined that all referred sixty-nine animals had gastroscopic 
evidence of gastric ulceration.  
Overall, we found a high presence (100%) of gastric ulcers in the horses examined. The group 
of horses examined, as with previous studies, was not randomly sampled and may only 
approximate the true prevalence of the disease in the population.  
The incidence found in the present study was higher than that found in previous studies 
(Niedźwiedź et al., 2013; Aranzales et al., 2014; Ward et al., 2015) where a prevalence of 50% 
was reported in sport and leisure horses in the UK, Poland  and Brazil or racehorses in Denmark 
and USA (Cate et al., 2012; Luthersson et al., 2009b). On the other hand, it matches the 
prevailing prevalence in racehorses (80-100%) reported in various locations around the world 
(Begg & O’sullivan, 2003; Bell, Kingston, Mogg, et al., 2007; Roy et al., 2005; Sykes, Sykes, et 
al., 2014b). This finding is not surprising, and the high occurrence may be explained by the 
inclusion criteria, as the horses in the present study were selected by presenting some clinical 
signs presumably attributed to EGUS. Also, as described previously, the number of selected 
cases was abridged by the failure to collect complete information from all the owners/caretakers 
of horses that met the inclusion criteria, and this could have led to attrition bias. We will discuss 
here the prevalence’s relative to the sample population (n=22). 
Some authors have been associating overall prevalence of ulceration with different sex groups, 
age and breed (Bell et al. 2007; Luthersson et al. 2009b; Orsini et al. 2009). We found gastric 
ulceration to be most prevalent in castrated males and ages between 6 and 10, whereas it was 
lower in females and stallions, which is in agreement with Rabuffo et al. (2002). Despite these 
findings, these risk factors were not found significant for the presence of EGUS nor for number 
and severity of ulcers as found by Cate et al. (2012) and Martinez and Silveira (2013). 
The high prevalence of gastric ulcers is well known in racehorses, and high-intensity training has 
been associated with an increased risk and severity of disease (Orsini et al., 2009; Ward et al., 
2015). In the present study, we found a higher prevalence in show-jumping horses (45,5%) 
versus other disciplines and in high-intensity training regime (68,2%), which is consistent with 
previous studies (Dionne et al., 2003; Luthersson et al., 2009b; Sykes et al., 2019). 
Another possible risk factor that has been appointed to gastric ulceration in horses is the horse's 
temperament as discussed by McClure and Glickman (1999), but in our study, only 27,3% of 
animals were described as aggressive and/or nervous. This factor is very hard to evaluate, as 
riders/caretakers might have a subjective opinion of the horse's attitude. Many studies have 
been conducted in the past to try to evaluate the human-animal relationship by judging 
behavioural characters using subjective scores (Cats: Turner et al. (1986), dogs: Goddard and 
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Beilharz (1983)). Then a simple test was developed to evaluate and score these interactions 
based on observations (Hausberger & Muller, 2002) and significant differences were identified 
between horses according to the caretaker. Mönki et al. (2016) succeeded in associating gastric 
lesions with a human-horse relationship factor, where the trainer and increased number of 
caretakers and riders were defined as possible risk factors for EGGD. Unfortunately, we were 
unable to achieve the same results. 
Similar to a previous study conducted at Lisbon Veterinary School Teaching Hospital (Simões, 
2011), the gastric mucosa was divided into five regions (oesophagus mucosa, squamous non-
glandular mucosa, margo plicatus, glandular mucosa and pylorus) in order to organise the 
lesions found in areas with similar aggression exposure. Consequently, the margo plicatus due 
to its capillary network and susceptibility to ischemic lesions was considered an independent 
region of the non-glandular mucosa (Staszyk et al., 2001). Then, the pylorus was considered an 
independent portion of the body of the glandular mucosa, because although possessing similar 
physiological characteristics, they have histological differences, such as the presence of mucin 
submucosal glands (Murray, Nout, et al., 2001b). Lastly, the oesophagus was examined upon 
withdrawing the endoscope as even though uncommon due to the nature of the cardia sphincter 
gastroesophageal reflux may occur (Andrews & Nadeau, 1999). 
The fasting period and procedures applied before endoscopy was generally enough to allow the 
non-glandular squamous mucosa to be assessed completely in all horses. Still, as the presence 
of residual feed material in a few areas of the glandular mucosa can complicate the evaluation of 
possible lesions in that area in a few cases, it is not certain that the smaller lesions were 
analysed (Andrews et al., 2002).  
The results gathered from both gastroscopic examinations in the present study are in agreement 
with the results obtained by others on the prevalence of ESGD and EGGD (Begg & O’sullivan, 
2003; Sykes & Jokisalo, 2015, 2015). Nearly all horses in this study (90,9% in the 1st exam and 
77,3% in the 2nd exam) presented lesions in the squamous non-glandular portion of the 
stomach, along the greater and lesser curvature near the margo plicatus which is in agreement 
with Tamzali et al. (2011). The lower presence of lesions in the glandular mucosa (68,20% in the 
1st exam and 63,6% in the 2nd exam) is consistent with previous reports  of 70.6% of EGGD in 
domesticated horses (Ward et al. 2015), while the lesions in the pylorus region (36,4% at 1st 
exam and 40,9% at 2nd exam) are somewhat similar to a previous report of 47% (Begg & 
O’sullivan, 2003), but less than the 58% found in another report (Murray, Nout, et al., 2001b). 
The relatively high incidence and severity of lesions in the glandular mucosa and pylorus area 
confirms the importance of a thorough assessment of all areas of gastric mucosa and justifies 
the recent emerging interest in EGGD (Luthersson et al., 2009b; Mönki et al., 2016; Sykes, 
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Sykes, et al., 2014b, 2014a, 2015), while gastroscopy continues to be the only method currently 
available to obtain a definitive diagnosis of  gastric ulcers (Camacho-Luna et al., 2018). 
As suspected, the oesophagus was the least affected region as only two horses presented 
lesions in the oesophagus mucosa in the second examination. 
As found in previous studies (Begg & O’sullivan, 2003; Murray, Nout, et al., 2001b), there was 
no association between the presence of lesions at one site and the other, and there was a low 
correlation between lesion score and location, with the pyloric ulcer score being the lowest. 
By analysing the epidemiological questionnaires, the clinical symptoms described were found 
vague and diverse, and for this reason insufficient for a definite diagnosis, but sufficient to 
consider EGUS as a differential diagnosis according to various authors (Hepburn, 2011; Murray 
et al., 1989; Sykes & Jokisalo, 2014; Wickens et al., 2013). 
The results of the epidemiological questionnaire demonstrated that the main factors were history 
of colic (presence of colic in the last year and/or recurrent signs of colic), signs of abdominal 
discomfort (oral stereotypes, bruxism, cribbing), behaviour changes (nervous/aggressive 
temperament and attitude, indifferent or sad posture), poor performance (lack of concentration 
and energy), and poor body condition (weight loss and dull coat).  
As found in previous studies (Dukti et al., 2010; Mönki et al., 2016) colic was one of the main 
clinical complaints, where 59,10% of horses presented with colic episodes in the last year and 
was significantly associated to ulcer scores. This finding is in line with previous studies 
(Hepburn, 2011; Murray et al., 1989) which stated that EGUS can occur in horses that present 
concomitant disease, where delayed gastric emptying increases the residual gastric fluid volume 
which results in a dorsal movement of acid, associated to pyloric disease and colic. On the 
contrary, Rabuffo et al. (2009) found that hospitalised colic patients are at higher risk to 
developing gastric ulceration due to management and environmental factors, but no association 
between developing EGUS and the complaint of colic.  
The horse’s mane and coat condition was the only other symptom significantly associated with 
ulcer scores. Curiously this was a surprising finding, as the author expected an association 
between the presence of a dull coat and an increase in ulcer severity but found a higher severity 
instead in horses with healthy shiny coats. This result confirms that gastric lesions can be 
prevalent in apparently asymptomatic horses (Cate et al., 2012; Fernandes et al., 2003; 
Niedźwiedź, Kubiak, et al., 2013). Nevertheless, poor body condition in horses in training has 
been associated with unresponsive posture and demeanour, consistent with illness, exhaustion, 
chronic pain, or depression-like states (Burn, Dennison, & Whay, 2010), even though 
assessment of behavioural changes such as temperament or posture can be difficult to interpret.  
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The correlations found in our study align with the proven previously published associations 
between ulcers and clinical symptoms (Belli, Silva, & Fernandes, 2005), namely the fact that the 
higher the ulcer degree, the greater the association between ulcers and clinical symptoms. 
Moreover, that ulcers lower than grade 2 are not likely to be associated with clinical findings or 
performance changes (Luthersson et al., 2009a; Sykes & Jokisalo, 2015).  
After treatment with omeprazole, there was a general improvement of symptoms and clinical 
complaints, especially related to colic, body condition (body weight and coat condition) and 
behavioural changes (Table 7). However, three new cases of bruxism during training were 
appointed. Another horse played with water, and yet another took longer to eat. Signs of 
abdominal discomfort such as playing with water, bruxism and/or cribbing are associated with 
EGUS (Murray et al., 1989), but can be frequently interpreted as bad habits by 
owners/caretakers, and if present during training can indicate problems with the horses bit or 
due to tooth wear, possible sharp edges on both the labial side of the upper cheek teeth and the 
lingual side of the lower cheek teeth or any dental abnormalities (Simões, 2011). 
Important to refer that there was a total abolition of colic symptoms in two cases, while three 
other cases did not register new episodes. Nevertheless, four cases increased the number of 
colic episodes (Table 6).  
Although not statistically significant, the general improvements registered after treatment with 
omeprazole show evidence that these unspecific and various symptoms might be associated 
with the presence of EGUS. 
During the physical examination, the prime change appointed was also a dull mane and coat. 
However, after treatment with omeprazole, none of the horses improved the mane and coat 
condition, and oddly one horse seemed worse. Although surprising, many diverse factors can be 
responsible for this fact, such as concomitant disease (e.g. endocrinal disease), nutritional 
factors (e.g. malnutrition), parasitism, age or even season of the year (the cold and wet season 
before shedding) (Scott & Miller, 2011).  
At first examination, six horses presented increased heart rate (>40bpm) as well as the 
respiratory rate, which can be explained by nervousness from being immobilised and in a 
strange environment. After treatment with omeprazole, five horses still presented increased 
heart rate, whereas the respiratory rate was increased in ten horses at the second examination, 
which could be related to the fact that they maintained a nervous temper. 
Reflecting the horse's circulatory status, hyperaemic and icteric colouration of the mucous 
membranes along with increased CRT were also a frequent detection in the study group. 
After treatment, only three horses with icteric mucous membranes changed to a normal moist 
and pink appearance. The horses with increased CRT returned to normal. Hyperaemic 
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membranes accompanied by normal or increased CRT are usually related to a septic or 
endotoxic condition associated with proximal enteritis, enterocolitis, prolonged strangulation 
obstructions, non-strangulating infarction or peritonitis. On the other hand, icteric mucous 
membranes are characteristic of patients with an obstructive biliary disease or associated with 
prolonged periods of decreased food intake or even anorexia (Moore, 2006).  
Decreased intestinal motility (cecum and colon motility) was another common clinical finding 
which improved after treatment with omeprazole. The absence or decrease of frequency and 
intensity of sounds at auscultation can be associated with different causes such as stress, 
alimentary factors (the type of feed, decreased intake, fasting), but also hypoperfusion during 
colic (Moore, 2006), however it was likely to be due to the fasting endured.  
Mouth examination in both periods detected the same number of horses needed dental care, as 
they presented uneven tooth wear and sharp edges on both the labial side of the upper cheek 
teeth and the lingual side of the lower cheek teeth. Just as any of the other clinical findings, the 
teeth could explain the weight loss (malnutrition), oral stereotypes (bruxism), poor performance, 
and aggressive posture when approached. 
Overall there was a general improvement of the horse's physical condition. However, the 
increase in body weight was the only significantly relevant changes confirmed after treatment 
with omeprazole, which demonstrates a positive association with the presence of EGUS. 
The lack of standardisation and vast diversity of scoring systems published prevents a better 
assessment and a correct comparison between clinical cases (Luthersson et al., 2009b).  
Despite the recent recommendations in the Consensus Statement (Sykes, Hewetsen et al. 
2015), we opted for an adaptation of the classification system of MacAllister et al. (1997), as it 
was the classification method used by the Teaching Hospital since the beginning. In spite of 
being emphasized by Sykes and Jokisalo (2014) that ESGD and EGGD should be considered 
as separate concepts, the classification of both types of mucosa was done together, according 
to the number of lesions and severity, since detailed image records of the gastroscopy of each 
horse was routinely stored, with no advantage in assigning a degree of classification by type of 
mucosa. 
The equine stomach presents a pH stratification, being the most alkaline pH near the 
oesophagus and acid at the pylorus level (Andrews & Nadeau, 1999; Merritt et al. 2003). 
Authors have found that low pH values (< 4) may contribute to the development of lesions in the 
nonglandular mucosa, as this region is inept of defence mechanisms towards acid injury 
(Nadeau et al., 2003).  
In the evaluated horses, it was not possible to relate the pH value of the gastric fluid with the 
degree of ulceration. We found animals with high levels of ulceration, with both high (pH = 4) 
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and low pH values (pH = 1.5), and horses with the same degree of ulceration had distinct pH 
values. Also, after therapy with omeprazole, in some horses, the pH values increased while in 
others, it decreased. Nevertheless, one cannot fail to mention that although the harvest was 
made at the level of the margo plicatus, several samples of gastric fluid (40,90% at first exam 
and 31.82% at control exam) had pH values lower than 4 which is considered ulcerogenic. Low 
pH values may partly be a consequence of fasting for gastroscopy preparation since horses are 
continuous producers of hydrochloric acid (Murray, 1994).  
Despite the lack of overall significant effect of treatment on gastric pH (p=0,210), it should be 
referred that the mean pH of the gastric fluid samples was higher in the horses after treatment 
(4.77; SD 1.37) than at first examination (3.98; SD 2.01) which indicates that omeprazole paste 
was effective in increasing gastric pH in horses. These results complement the results from 
previous studies which investigated the therapeutic application of omeprazole in horses 
(Andrews, 2015; Andrews, Frank, et al., 2006; Andrews & Nadeau, 1999; Huxford et al., 2017; 
Merritt et al., 2003; Sykes, Underwood, et al., 2017; Videla et al., 2011) 
Many animals presented a high numeric score (n=13/22) and high ulceration severity (n=5/22) 
on the first gastroscopy. After treatment with omeprazole, regardless of the high grades 
attributed to each horse according to the above mentioned scoring system, it is essential to point 
out that several animals (45.5 %, 10/22) presented lesions with a healing aspect and a less 
severe injury compared to first gastroscopies performed, with two cases of total remission 
(9.1%). However, injuries of a more aggressive nature remained unsolved (36.36%, 8/22), while 
others still suffered an increase in lesion number and severity (18.18%, 4/22). 
In order to assess the efficacy of the treatment, the endoscopic evaluations should have been 
performed following medical treatment. However, the re-evaluation examinations were 
performed at different periods. Most horses (86.4%) were re-evaluated between one and four 
months when the treatment lasted two months. Therefore, some horses exceeded the treatment 
period. Furthermore, there was a tendency for the endoscopic screening interval between 4-6 
months to present an increase in the number of gastric ulcers.  These results suggest that the 
high discrepancy in screening intervals in the study group may be associated with a lower 
treatment response and/or a possible recurrence of the gastric ulceration. Authors in previous 
studies have reported different levels of treatment response to the standard recommended a 
treatment duration of 2x28 days, suggesting that given the pathophysiology differences between 
ESGD and EGGD, some cases may require different treatment durations (Sykes et al. 2014; 
Sykes et al. 2014a; Sykes et al. 2015). Thus, the importance of repeating gastroscopy at either 
28 or 56 days.  
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Alongside the pharmacological therapy, in order to lessen ulcer severity and avoid recurrence of 
the lesions, long-term environmental and dietary management changes were recommended 
(Andrews et al. 1999; Andrews et al. 2017). The remission of the gastric lesions should be 
expected to be all the more exuberant, the greater the number of risk factors corrected (Videla & 
Andrews, 2009). 
Overall, the management changes were partially implemented in most cases, where 
environmental changes where consented partially in 63.64% (14/22) and dietary changes in 54-
55% (12/22) of cases. Still, there were cases of total implementation, 40.91% (9/22) referring to 
dietary changes and solely 4.55% (1/22) to environmental changes. However,  the changes that 
were reported to have the highest accession in the study group were the dietary changes, such 
as addition of oils, a decreased in size while increasing the frequency of grain in 81,8% (18/22), 
also an increase of forage and fibre by access to continuous feeding in 90,91% (20/22) of cases. 
Effective acid control is accomplished by dietary management strategies (Andrews et al. 1999b; 
McClure et al. 2005), such as increasing forage intake, eliminating bolus feeding, decreasing the 
size and increasing the frequency of concentrate feeding. 
The level of owner compliance reported in this study may be due to the fact that the horse's diet 
can be managed and readily modifiable (Luthersson et al., 2009a). Whereas environmental 
changes, such as access to pasture/paddock or adding company in many cases is not feasible 
as many horses are kept in suburban and urban areas (Houpt, 1987). Also, reducing the level of 
exercise in high-level competition horses can prove difficult. 
Although the implementation of the aforementioned changes has been reported to help control 
gastric ulceration, in this study, there were no significant differences in either numeric or severity 
score evolution identified for any possible type of implementation. Nonetheless, analysing the 
score evolutions according to the different level of implementations, the author verified that 
45.5% (10/22) of the horses that demonstrated a decrease in numerical and severity score were 
mostly those who had implemented the management changes in some way. From the horses 
which demonstrated decreased numeric score, nine horses had environmental and dietary 
changes implemented in some way. Whereas from the horses with decreased severity scores, 
eight horses had environmental changes implemented partially, while nine horses had dietary 
changes implemented. These results suggest that associating long-term management changes 
may help control and decrease the chance of recurrence of gastric ulcerations. 
At control gastroscopy, two cases of total remission were observed, indicating a positive 
response to the omeprazole paste, in the treatment dose of 4mg/kg bwt PO for 28 days, followed 
by the maintenance dose of 2 mg/kg bwt for 28 days (Direção Geral de Alimentação e 
Veterinária 2018).   
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From the four horses that presented an increased number of lesions at control exam, only two 
showed an increase in severity. The horse that changed from a severity grade 2 to a grade 4 is a 
9-year-old show-jumping stallion with a high-level exercise regime. The high-level of exercise, a 
well-reported risk factor for EGUS (Pedersen, 2017), may be the possible cause of inferior 
treatment response in this case.  The level of exercise was not reduced even after 
recommendation and only a few of the dietary changes were implemented (addition of oil, low 
doses and increase of meal frequency). As discussed above, there is evidence that reducing 
exercise decreases the risk of ESGD. However, without changes in management, squamous 
ulcers may quickly return if horses are maintained in training (Andrews, Sifferman, et al., 1999). 
Also, the re-evaluation of this horse was performed 4 months post-treatment, which might have 
heightened the opportunity for recurrence (Sykes, Sykes, et al., 2014d, 2014a, 2015).  
The horse that changed from a severity grade 1 to a grade 3 is a 22-year-old gelding leisure 
horse who was evaluated after an episode of colic and had been given by mistake an excess 
dose (15,5mg/kg bwt SID) of a top-dress formulation of Suxibuzone (Danilon®, Ecuphar16). 
Danilon® is a NSAID which comes in sachets of a yellow, odourless granules to add to the 
horses feed with a recommended label dose at 6,25 mg/kg bwt (equivalent to 2 sachets of 
10g/480kg bwt) BID, for the first two days, and a half the dose (3,1 mg/kg bwt BID) the following 
3 days. If necessary, this maintenance dose can be given SID or every other day until a positive 
clinical response is achieved (Direção Geral de Alimentação e Veterinária 2019). Previous 
research suggests the NSAIDs as primary agents in the development of EGGD if used in 
excessive doses or prolonged treatments (MacAllister et al., 1993; Martínez Aranzales et al., 
2015). Although, authors have suggested that NSAIDs given at recommended doses are 
unlikely to cause EGUS (Andrews et al., 2009; Nieto et al., 2012). There is conflicting evidence 
regarding the influence of NSAIDs on the development of EGUS (Sykes, Hewetsen et al., 2015). 
Nevertheless, in the authors opinion, the age should be taken into consideration, as increased 
risk is associated with elderly horses (Direção Geral de Alimentação e Veterinária 2019). 
Additionally, it was referred that even after treatment with omeprazole along with dietary (oil’s, 
hay add libitum and feeding practices) and management changes (access to paddock), the 
horse in question did not gain weight neither did the coat's condition improve. However, this can 
be explained again by the horses' age, chronic pain given the severity of the gastric lesions 
(Burn et al., 2010; Scott & Miller, 2011) and the abnormal dental wear characteristic of elderly 
horses (Andrews et al., 2017) and the non-correction of this situation even after 
recommendation. Even though increased lesion scores were observed in the second 
 
16 Ecuphar NV, R. Sintra Business Park, 2710-089 Sintra, Portugal. 
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examination, the lesions in the glandular mucosa identified in the first examination healed in 
contrast with the one in the squamous mucosa, which suggests a positive response to the 
omeprazole therapy associated with the recommended long-term changes.  
The remaining two horses that maintained the severity scores, both presented severity score > 
2. One was a nervous tempered, 12-year-old mare used in high-level show-jumping, which in the 
first examination referred poor performance for over a year, had been diagnosed with ESGD 
three months prior and had previously been treated with GastroGard® and ranitidine. However, 
even after another round of treatment with the recommended label dose of omeprazole, in the 
second examination, this horse maintained the grade 2 severity lesions, along with lesions 
identified in the glandular region. In the author's opinion, the low treatment response can be 
justified by the low compliance to the recommended long-term environmental management 
changes, as the level of exercise was not reduced, nor did the horse have access to paddock. 
Regarding dietary management, the only change that was not assumed was the addition of oil to 
the diet, a reported effective option to increase the protection properties of the glandular 
mucosa, as discussed above (Cargile et al., 2004). Also, it should be referred that the follow-up 
examination was performed after six months, instead of the recommended interval, which might 
explain the possible recurrence and worsening of the gastric lesions. 
The other horse that maintained a severity score grade 3 was a 7-year-old stallion used in 
Dressage, with a reported difficulty in the gallop gait over the course of the year as the only 
complaint. Despite the treatment with omeprazole at label dosage and recommended duration, 
associated with nearly a total implementation of the long-term management changes, there was 
still a low treatment response. These results may suggest the need for increased treatment 
duration, as there were lesions identified in both glandular and squamous mucosa.   
The remaining eight horses presented involution of the lesions. Even in those that continued to 
present high degrees of ulceration, the lesions appeared to be healing. This demonstrates the 
importance of keeping records of the observed lesions so that there can be a comparison 
between the appearance of the mucosa before and after therapy. The use of a system of 
classification of the lesions found in the stomach is a useful and simple way to assess the 
number and severity of these lesions, thus obtaining a general overview of the state of the 
gastric mucosa of the horse. However, classification systems are not sufficient to assess the 
evolution of the lesions initially observed, so it is necessary to maintain records of the 
appearance and location of the main lesions, notably through film and photographs, as shown by 
the results obtained in this study. 
Parasites do not seem to have played an important role in the aetiology of these twenty-two 
cases of EGUS. However, organisms from the genus Gastrophilus were identified in only one 
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horse during both examinations. This horse was a nervous tempered, 2-year-old filly, trained for 
endurance with a high-level exercise regime. Therefore, in the author's opinion, various risk 
factors such as exercise, age and temperament may have played a role in the development of 
gastric ulcers in this case, other than parasites.  
 
5. Conclusion 
The results of the present study showed a prevalence of 100% of gastric ulceration in the target 
population, confirming the presence of some degree of EGUS in the initial group composed of 
sixty-nine animals. However, as these animals were not randomly chosen, it should be assumed 
as only an estimate of the real prevalence of the disease in the population. Also, due to 
incomplete clinical history information or lack of follow-up examination, the final sample 
population was reduced to 22 horses, which might have led to attrition bias. 
The high numerical and severity scores of the ulcer lesions observed in several of the horses, 
according to an adaptation of the classification system by MacAllister et al. (1997), demonstrated 
a certain character of aggressiveness, with seventeen horses holding a numerical grade > 3 and 
ten horses holding severity grades > 4. Considering the aggressive nature of the lesions, the 
symptomatology presented in our sample population was in general as exuberant as would be 
expected, although very unspecific. The most frequent clinical signs reported were history of 
colic (presence of colic in the last year and/or recurrent signs of colic), signs of abdominal 
discomfort (oral stereotypes, bruxism, cribbing), behaviour changes (nervous/aggressive 
temperament and attitude, indifferent or sad posture), poor performance (lack of concentration 
and energy), and poor body condition (weight loss and dull coat).  Moreover, the higher the ulcer 
degree, the greater the association between ulcers and noticeable clinical symptoms (colic and 
coat condition). However, higher severity scores were found in horses with healthy shiny coats, 
which corroborates the fact that EGUS often exists in apparently asymptomatic horses. 
Although gastric ulceration lesions were found most frequently in castrated males, horses aged 
between 6 and 10, and show-jumping horses, none of the presumable risk factors was found 
significantly associated with the number or severity of gastric lesions.   
Therefore, in order to obtain a definite diagnosis of gastric ulceration, the only currently available 
method is an endoscopic examination of the gastric mucosa, since parameters such as age, 
gender, performance, behaviour, eating habits provide only weak clues as to which horses might 
be affected. 
Gastric lesions were found more prevalent in the squamous non-glandular mucosa than in the 
glandular mucosa (including pylorus), which is in agreement with previous prevalence studies of 
ESGD and EGGD. Still, the high incidence and severity of lesions found in the glandular mucosa 
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and the pylorus area should prove the importance of a detailed and systematic assessment of 
gastric mucosa and gives reason to the emerging attention to EGGD. 
It was not possible to correlate the measured pH values with gastric ulceration, although the low 
pH values cannot be ruled out as a consequence of fasting before gastroscopy. However, 
several horses withstood pH < 4, which is considered ulcerogenic. 
The results obtained in this group of horses met the already tested efficacy of omeprazole in the 
treatment of gastric ulcer, with observed cases of complete remission. Most horses presented 
lesions with a healing aspect, as even the ones without complete remission tended to be less 
severe.  
The positive healing response of the lesions, along with a confirmed increase in mean pH, was 
accompanied by a general improvement of physical condition, symptoms and clinical complaints, 
which also demonstrates a positive treatment response with omeprazole paste. Still, there were 
identified cases of lesion aggravation/recurrence possibly due to a discrepancy in screening 
intervals, along with the role of individual dose responsiveness, indicating the importance of 
follow-up examinations in the recommended intervals. 
The recommended long-term environmental and dietary management changes were found to 
have an important role in the success of the treatment. The therapy was more effective, the 
greater the number of risk factors corrected, namely the implementation of long-term 
management changes.  
Although not significantly associated with the level of gastric ulceration, risk factors such as age, 
exercise and administration of NSAIDs may have determined a lower treatment response in 
certain animals.  
As with any questionnaire-based analysis, recollection bias may have been present. Owners 
may fail to reveal medications administered or may not accurately recall management practices. 
Also, clients sensitive to their horse's gastrointestinal health may have more accurate recall as 
they may pay more attention to their horse's management than someone not concerned about 
gastric disease in their horse. In conclusion, the level of co-operation and compliance of the 
owners/riders is essential for the therapy to succeed. 
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IV. Further studies 
Due to the negative impact of EGUS on the equine industry, further studies are required to 
determine the aetiology of the syndrome and to find ways to reduce, if possible, the frequency of 
gastric ulcers. 
Also, more attention should be given to individual assessment of gastric mucosa to improve the 
quality of EGUS prevalence studies. A correlation between anatomical location and lesion 
scores, and the anatomical distribution by age, by gender and type of work, would provide very 
relevant information.  The apparent differences in the prevalence of lesions in the different 
regions of the stomach should be further investigated and, where sufficient cases are available, 
risk factors for each location should be investigated. 
This study was performed with a quite diverse population and several variables. So, it would be 
interesting to reduce the variables by increasing inclusion criteria and to extend the study to a 
larger sample population, in order to study specific risk factors for EGUS, such as level of 
exercise and age.  
Most prevalence studies focus on Thoroughbred or Standardbred racehorses worldwide. 
However, despite the growing demand for Lusitano breeds abroad, little research has been done 
regarding the prevalence of gastric ulceration in the Lusitano Purebred horse, to the author's 
knowledge. Further prevalence studies are also required regarding horses used in other 
demanding equestrian sports, such as Horseball and Working Equitation. 
Recent research on the use of alternative proton pump inhibitor therapy has been reported, such 
as esomeprazole (both oral and i.v.) and a novel, long-acting, injectable formulation of 
omeprazole, but this still requires further evidence, and further investigation of it’s use in cases 
where oral omeprazole therapy is ineffective or inappropriate. 
Furthermore, additional clinical trials are essential to discovering alternative, effective, and low-
cost therapies for gastric lesions in the horse in order to allow higher owner compliance. 
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VI. Annexes 
 
Annexe 1a. Submitted and accepted abstract for poster presentation for the IV Jornadas 
do GTIE (11th November 2015) 
Uso da gastroscopia na Avaliação da Evolução do Tratamento de Síndrome de Úlcera Gástrica 
Equina (SUGE)  
FILIPA GRAÇA PAIT CORTEZ17, JOANA DE SOUSA AZEVEDO SIMÕES24, JOSÉ PAULO SALES 
LUÍS24, PAULA ALEXANDRA BOTELHO GARCIA DE ANDRADE PIMENTA TILLEY. 24 
A SUGE constitui um grave problema do ponto de vista económico e clínico pela sintomatologia 
inespecífica e efeitos negativos no desempenho desportivo1. Os princípios ativos mais utilizados são 
eficazes, mas dispendiosos e com elevada taxa de recorrência1.  É essencial tomar simultaneamente 
medidas preventivas, como redução da estabulação, forragem ad libitum, redução de exercício/stress1. 
Foi objetivo deste trabalho avaliar por gastroscopia a evolução do tratamento e identificar os fatores de 
risco da SUGE. 
Foram avaliados 68 cavalos com suspeita de SUGE através de exame clínico, pesagem, gastroscopia, 
medição do pH gástrico e inquérito epidemiológico. Os cavalos que apresentaram graus de ulceração ≥ 2 
(MacAllister) foram medicados com Omeprazole PO (GastroGard™, Merial). Cavalos com grau de 
ulceração inferior a 2 (MacAllister) foram medicados com GNF (TRM) e sucralfato genérico. A todos os 
cavalos foram recomendadas medidas preventivas como alterações no maneio alimentar e redução do 
stress. Apenas 35 cavalos foram reavaliados 2-6 meses após o tratamento. 
Confirmou-se a ocorrência de SUGE no grupo estudado, sendo identificada sintomatologia com 
relevância clínica e relativa ao desempenho desportivo. Após terapêutica com GastroGard™ observou-se 
franca melhoria das lesões e dos sinais clínicos, tendo-se verificado remissão total das lesões em 2 
cavalos. A terapêutica com GNF (TRM) mostrou ter alguma eficácia, tendo sido observada ligeira 
melhoria das lesões e sinais clínicos. 
Reforçou-se a relevância de se realizar história pregressa e exame fisico detalhados para ponderar 
realizar a gastroscopia, sendo este o único meio de diagnóstico in vivo de SUGE. Verificou-se que fatores 
de risco como alimentação, maneio, exercício e stress têm grande influência na ocorrência e evolução da 
SUGE, sendo fulcral a sua identificação e correção atempada. A terapêutica foi tanto mais eficaz, quanto 
maior o número de fatores de risco corrigidos. Concluiu-se ainda a importância da cooperação dos 
proprietários/cavaleiros para que a terapêutica tenha sucesso. 
 
Bibliografia: Nadeau, JA, Andrews, FM. 2009. Science: Overviews - Equine gastric ulcer syndrome: The 
continuing conundrum. Equine Veterinary Journal, 41, 611-615. 
 
17 Departamento de Clínica, Faculdade de Medicina Veterinária, Av. Universidade Técnica, 1300-477 Lisboa, Portugal 
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Annexe 1b. Poster presented at the IV Jornadas do GTIE (11th November 2015) 
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Annexe 2. Epidemiological questionnaire 
      
Questionnaire on the horse’s behaviour 
Number:                 Date:                           
1- Horses Name:     Date of birth:                         
2- Rider’s name/Groom’s name:  
3- Temperament:  Docile      Aggressive        Calm Nervous   
4- Colic in the last year:  Yes  No 
a. Duration: ½ day       1 day       2 days        3 days        >3days   
b. Pain scale: Very mild       Mild  Moderate      Severe       
Very severe        Violent  
c. Medication?  Yes No  
5- Presents signs of mild colic once in a while? Yes   No   
(Colic that manifest by signs of mild discomfort, appears lying down frequently, doesn’t eat 
full meal, but eventually recovers with diet, walking, or one minimal dose of Vetalgin.) 
6- Plays with water in drinking bowl? Yes  No  
Lays snout in drinking bowl? Yes No   
Swallows air (“Crib-biting”)? Yes  No  
7- Grinds teeth when stabled?  Yes No 
Grinds teeth during training? Yes   No  
8- Takes a long time to eat? Yes No 
Eats everything once food is given? Yes  No 
Eats partially once is given, and leaves a portion to eat throughout a period of time? Yes 
 No  
9- Horse turns rear when entering the stall?  Yes  No 
When someone opens the door to the stall the horse stays still?      Approaches the 
person?           
10- Horse is sad? Yes  No 
Horse is lacking energy during training? Yes  No 
11- Horse lacks concentration during training? Yes  No 
Horse is unlearning?  Yes  No 
12- Do you think the horse has lost weight?  Yes No 
Do you think the horse shows signs of abdominal discomfort? Yes No  
Do you think the horse’s coat has turned dull? Yes  No 
Notes:   
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Annexe 3. Gastroscopy report form 
GASTROSCOPY………….. nº_________/_________  
DATE  Horse’s Name  Weight  
  
GASTROSCOPY – LESION NUMBER SCORE 
0  No lesions    
1  1-2 localized lesions    
2  3-5 localized lesions   
3  6-10 lesions    
4  > 10 lesions or diffuse (or very large lesions)    
   
GASTROSCOPY – LOCATION    
Glandular    
Non-glandular    
Both   
 
  GASTROSCOPY – LESION SEVERETY SCORE  
0  No lesions   
1  Appears superficial (only mucosa missing)    
2  Deeper structures involved (greater depth than nº1)   
3  Multiples lesions and variable severity (1,2 and/or 4)    
4  Same as 2 and has active appearance (active=hyperaemic and/or darkened lesion 
crater) 
  
5  Same as 4 plus active hemorrhage or adherent blood clot   
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 BIOPSY HARVESTING 
Number of fragments__________________            Urease test_________________  
GASTRIC FLUID COLLECTION             pH __________  
ENDOSCOPY REPORT  
FUTURE THERAPEUTIC INDICATIONS  
  
   Veterinary Physician _____________________________________________________  
 
101 
 
Annexe 4. Questionnaire on treatment follow up 
 
Treatment Follow up 
Horse: Owner: 
Gender: Rider (s): 
Discipline:  Groom (s): 
Training regime:  
Frequent medication: 
 
Measures implemented after recommendation 
I. Pharmacologic therapy 
 
Pharmacologic 
agent 
Yes No Notes 
Omeprazole    
Cimetidin    
Ranitidin    
Sucralfate    
Other(s)    
 
 
II. Environmental Management 
 
Environmental Factors Yes No Notes 
Reduce exercise intensity    
Pasture/paddock turnout    
Company    
Improve stable conditions (lighting, aeration, area)    
Others    
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III. Dietary Management 
 
Diet changes Yes No Notes 
Add Oils (corn, olive)     
Increase forage and 
fibre 
   
Add Alfalfa hay    
Continuous feeding    
Decrease size and 
increase frequency 
of concentrate 
feeding 
   
Calcium carbonate 
supplements 
   
Concentrated 
electrolyte paste or 
solutions 
   
Salt    
Vitamins    
Others    
 
 
 
 
Notes:   
 
 
 
 
 
 
 
